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I. INTRODUCTION 
 
I.1. Lymphocyte homing receptor: L-selectin  
In the 1950s and 1960s Gowans and collaborators noticed that lymphocytes continuously 
recirculate from the blood into the lymph nodes and then back into the blood (Gowans 
and Knight, 1964; Marchesi and Gowans, 1964). This migration or homing of 
lymphocytes into the peripheral lymph nodes (PLN) is necessary to expose lymphocytes 
to antigens. As demonstrated by histological studies, circulating lymphocytes migrate 
into the tissues through the postcapillary venules of lymph nodes, which are 
characterized by cuboidal endothelial cells (Ford et al., 1969; Ford, 1975). In 1976 
Stamper and Woodruff were able to demonstrate, in vitro, that lymphocytes bind to the 
high endothelial venules (HEV). They added fresh lymphocytes to frozen sections of 
lymph nodes and observed their binding. Later, antibodies were developed to block 
lymphocyte binding to HEV and to identify the adhesion molecules involved in 
lymphocyte homing to PLN and to sites of inflammation. A great number of different 
adhesion molecules were identified, including three proteins which belong to the family 
of selectin proteins: E-, P- and L-selectin. Selectins (Figure I.1.1) are C-type lectin 
calcium-dependent proteins expressed by bone marrow-derived and by endothelial cells.  
 
 
Selectin 
    L-        E-        P- 
 
 
Figure I.1.1.  Selectin family proteins.  Schematic representation of L-, E- and P-selectin proteins. 
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Due to their involvement in the migration of leukocytes into PLN and inflamed tissue 
(McEver et al., 1991), these molecules have received great attention and have been 
studied in detail. In vitro, selectins were demonstrated to be involved in neutrophil 
adhesion to cytokine-stimulated endothelial cells (Smith et al., 1991; Bargatze et al., 
1994) and in neutrophil rolling under shear stress (Lawrence et al., 1993; Abbassi et al., 
1993; Fuhlbrigge et al., 1996). In vivo, all three selectin proteins were shown, 
independently, to take part in leukocyte rolling on the endothelium (Doré et al., 1993; 
Ley et al., 1993; Ley et al., 1995; Finger et al., 1996). 
L-selectin is the homing receptor for lymphocytes at high endothelial venules (HEV) 
within peripheral lymph nodes (PLN). It is localized on the microvilli of naïve T cells, 
myeloid cells (Kansas, 1996) and central memory T cells (Sallusto et al., 1999). In vivo, 
L-selectin mediates rolling of circulating lymphocytes on HEV (Von Andrian et al., 
1995; Warnock et al. 1998; Stein et al., 1999). The monoclonal antibody MEL-14, in 
vivo, completely blocked the migration of lymphocytes from the blood into PLN, but not 
into Peyer’s patches (Gallatin et al., 1983; Geoffroy and Rosen, 1989), by binding the 
lectin domain of L-selectin (Bowen et al., 1990). While E- and P-selectins were 
demonstrated not to be involved in lymphocyte migration into the central nervous system 
during inflammation (Engelhardt et al., 1997), L-selectin was demonstrated to be 
involved in lymphocyte binding to myelinated regions of the CNS. Rosen and his co-
workers demonstrated that L-selectin binds, on brain and spinal cord frozen sections, to 
the white matter regions and this binding can be impaired by adding the monoclonal 
antibody MEL-14  (Huang et al., 1991). L-selectin (CD62L) used to be called LECAM-1 
(leukocyte-endothelial cell adhesion molecule-1), Ly-22 (lymphocyte antigen-22), Leu8 
(leukocyte surface antigen-8), TQ1, DREG-56, and LAM-1 (leukocyte adhesion 
molecule-1), but these terms are no longer in use. In fact, after cloning and sequencing 
(Tedder et al., 1989; Siegelman et al., 1989; Lasky et al., 1989), L-selectin was identified 
as a type-I membrane protein composed by different domains which are all involved in 
the regulation of L-selectin function. The cytoplasmic tail is important for the anchorage 
of L-selectin to the cytoskeleton and modulates the ability of L-selectin to mediate 
tethering and rolling of lymphocytes along HEV (Kansas et al., 1993). In fact, tail-
truncated L-selectin molecules were created and it was demonstrated that the 6 amino 
acids in close proximity to the cell membrane are important for the localization of L-
selectin on microvilli. Instead, the last 11 amino acids at the C-terminus are important for 
the anchoring of L-selectin to the cytoskeleton (Dwir et al., 2001), which is mediated by 
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α-actinin (Pavalko et al., 1995) and by the ezrin-radixin-moesin (ERM) proteins (Ivetic 
et al., 2002; Ivetic et al., 2004; Ivetic and Ridley, 2004). A correct linkage of L-selectin 
to the cytoskeleton was shown to facilitate ligand binding, to stabilize tethering and to 
switch tethering to rolling (Schwarz et al., 2004). The binding of L-selectin to its 
carbohydrate ligands is mediated by calcium-dependent lectin domain at the N-terminus. 
The first suggestion that carbohydrates play a role in lymphocyte homing was made by 
Gesner and Ginsburg in 1964. Their hypothesis was then confirmed by Stoolman and 
Rosen: they demonstrated that cell surface carbohydrates on the endothelium and 
carbohydrate-binding molecules on lymphocytes contribute to lymphocyte homing at 
HEV (Stoolman et al., 1983). Lymphocytes are able to recognize HEV (Jalkanen et al., 
1986; Berg et al., 1989) because HEV present specific carbohydrates on their luminal site 
(Streeter et al., 1988; Berg et al., 1989). The presence of these HEV specific antigens was 
defined by MECA-79. MECA-79 is a monoclonal antibody binding to specific sulphate- 
and fucose-dependent carbohydrate epitopes on HEV and is able to block lymphocyte 
extravasation into PLN. In vitro, MECA-79 binds to epitopes on the surface of high 
endothelial venules of peripheral lymph nodes and not to the HEV of the mucosa-
associated lymphoid organs like Peyer’s patches (Streeter et al., 1988). L-selectin and 
MECA-79 precipitated the same proteins (Imai et al., 1991), thus the protein complexes 
recognized by MECA-79 were thought to include also L-selectin ligands. Both L-selectin 
and MECA-79 bind to O-glycans attached to serine and threonine residues on 
glycoproteins which are called mucins or peripheral node addressin (PNAd) (Figure 
I.1.2). The O-glycans contain tetrasaccharides rich in fucose moieties and sialic acid 
called sialyl Lewis X (sLeX). The structural analysis of sialomucins confirmed that L-
selectin and MECA-79 require sulfation of sLeX (6-sulfo sLeX) to bind their fucosylated 
ligands (Moore et al., 1991; Hemmerich et al., 1994; Toppila et al., 1997; Renkonen et 
al., 1997). In fact, recently two independent studies focused on GlcNAc6ST-1 and -2 (N-
acetylglucosamine-6-O-sulfotransferase-1 and -2), which are the enzymes responsible for 
the correct biosynthesis of 6-sulfo sLeX, and confirmed the biological relevance of 
sulfation for lymphocyte homing in vivo. Mice lacking both sulfotransferases were 
shown to have an impaired recruitment of lymphocytes into PLN and the 6-sulfo sLeX 
and the MECA-79 epitope are missing on HEV (Kawashima et al., 2005). Using 
intravital microscopy, in GlcNAc6ST-1 and -2 knock-out mice, only few lymphocytes 
were seen to roll on HEV and their rolling velocity was higher compared to wild type 
mice (Uchimura et al., 2005). In both studies, could be still detected a minor group of 
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lymphocytes homing to PLN, suggesting that L-selectin can bind also ligands which are 
not recognized by MECA-79, such as PSGL-1. In addition, it was demonstrated that the 
absence of fucosylation provokes absence of L-selectin ligands on HEV and therefore a 
reduction in the number of lymphocytes in the PLN (Maly et al., 1996; Homeister et al., 
2001; Piccio et al., 2005). 
 
 
6-sulpho sialyl 
Lewis X 
 
 
Figure I.1.2. Peripheral node addressin and MECA-79 antibody. (Modified from R.P. McEver, 2005. 
Nature Immunology 11(6): 1068).  The L-selectin binding determinant 6-sulpho sialyl Lewis X is created 
by two Golgi enzymes (GlcNAc6ST-1 and -2) which attach sulphate esters to GlcNAc residues on the 
sLeX group. MECA-79 recognizes mucins on HEV. 
 
 
 
 
PSGL-1 (P-selectin glycoprotein ligand-1) (Figure I.1.3) is a disulfide-bonded 
homodimeric mucin-like glycoprotein of 120kDa which is expressed, on leukocytes, on 
the top of microvilli (Moore et al., 1995). During inflammation, PSGL-1 can bind P-
selectin and mediates leukocyte-endothelial and leukocyte-platelet adhesion, but PSGL-1 
can also mediate leukocyte-leukocyte interaction by binding to L-selectin (Walcheck et 
al., 1996; Moore, 1998). In neutrophils, L-selectin and PSGL-1 interact and mediate 
leukocyte recruitment to inflamed tissues (Spertini et al., 1996). L-selectin binding to 
PSGL-1 requires that the ligand has an appropriate glycosylation (Cummings et al., 
1999) and can be blocked by antibodies (Guyer et al., 1996; Snapp et al., 1998). 
Furthermore, the binding is calcium-dependent and is regulated by the lectin domain with 
the EGF domain and the two consensus repeats sequences of L-selectin (Tu et al., 1996). 
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The glycosylated ligands for L-selectin on HEV, GlyCAM-1, CD34 and the novel ligand 
endomucin (Figure I.1.3), were identified using the MECA-79 antibody. 
 
MAdCAM-1 
CD34 
 
 
Figure I.1.3. L-selectin ligands GlyCAM-1, CD34, PSGL-1, MAdCAM-1 and endomucin. Schematic 
representation of glycosylated L-selectin ligands expressed on HEV or leukocytes. 
 
 
GlyCAM-1 (glycosylation-dependent cell adhesion molecule-1) was isolated from 
culture media of mouse lymph node (Imai et al., 1991). It was first named sulfated 
glycoprotein Sgp50 because of its molecular weight of 50kDa and only after sequencing 
was it recognized as a mucin-like adhesion molecule (Brustein et al., 1992; Lasky et al., 
1992). GlyCAM-1 is detectable, by immunocytochemistry, in the intracellular vesicles of 
high endothelial cells and not on the surface of HEV, suggesting that GlyCAM-1 is 
secreted, upon inflammatory stimuli, in a sialylated form into the blood (Imai et al., 
1993; Kikuta et al., 1994), where it binds soluble L-selectin (Hemmerich et al., 1994; 
Suguri et al., 1996). 
The second L-selectin ligand identified using MECA-79 was CD34 (Baumhueter et al., 
1993; Baumhueter et al., 1994), which was first named Sgp90 because of its molecular 
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weight (Imai et al., 1991). The sialomucin CD34 is abundant in serine, threonine and 
carbohydrates and can support lymphocyte adhesion under shear flow in vitro (Puri et al., 
1995). CD34 is a transmembrane glycoprotein expressed on HEV (Lin et al., 1995), 
where it is sulfated to bind L-selectin. CD34 is also expressed in a non-sulfated form on 
hematopoietic precursor cells, where is not an L-selectin ligand. Electron microscopy 
revealed that CD34 is expressed on the luminal site of HEV and is localized at cell 
junctions (Fina et al., 1990). 
Endomucin is a novel ligand for L-selectin. It was previously identified as an endothelial 
sialomucin (Morgan et al., 1999), but more recent investigations have shown that 
endomucin is also expressed on the luminal site of HEV in lymphoid organs and carries 
the MECA-79 epitope. Because of its expression on HEV and the presence of the 
MECA-79 epitope, endomucin is considered to be a ligand for L-selectin (Samulowitz et 
al., 2002) and supports L-selectin-mediated rolling of lymphocytes on HEV (Kanda et 
al., 2004). 
Lymph node high endothelial venules present Sgp200, which is another sulfated 
glycoprotein, not yet characterized, that binds soluble L-selectin via the carbohydrate 
groups (Hemmerich et al., 1994).  
L-selectin also binds to another ligand which is expressed on HEV in mucosa-associated 
lymphoid tissue (MALT) and gut-associated lymphoid tissue (GALT) (Berlin et al., 
1995). This ligand (Figure I.1.3), the mucosal addressin cell adhesion molecule-1 
(MAdCAM-1), was recognized by the monoclonal antibody MECA-367 and is the ligand 
for α4β7 integrin on Peyer’s patches and mesenteric lymph nodes (Streeter et al., 1988; 
Berlin et al., 1993; Briskin et a., 1993; Bradley et a., 1997). MAdCAM-1 is a 60kDa 
protein which is recognized by the lectin domain of L-selectin. In fact, L-selectin 
recognizes and binds to a mucin-like structure of MAdCAM-1 (Berg et al., 1993). 
MAdCAM-1 expression can be increased in vitro and in vivo upon inflammation 
(Sikorski et al., 1993).  
The generation of L-selectin-deficient mice allowed an improved investigation of the role 
of L-selectin in lymphocyte homing in vivo. The L-selectin-deficient mice were 
generated in the early 1990s by gene targeting, and their characterization reported an 
unique phenotype. Lymphocytes from those mice do not bind to HEV and, compared to 
the wild type littermates, the L-selectin knock-out mice had a strong reduction in 
lymphocyte recruitment into PLN (Arbones et al., 1994; Catalina et al., 1996) and an 
increased splenic cellularity (Steeber et al., 1996; Steeber et al., 1996). The role of L-
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selectin in inflammation is controversial. In fact, L-selectin-deficient mice have shown an 
impaired migration of neutrophils, lymphocytes and monocytes into the inflamed 
peritoneum, indicating that L-selectin also plays a role in cell migration into non-
lymphoid tissues (Tedder et al., 1995). Indeed, no significant difference was reported in 
lymphocyte homing to inflamed skin in L-selectin-deficient mice (Catalina et al., 1996).  
Many investigations focused on the involvement of L-selectin in leukocyte-leukocyte 
interaction during inflammation (Tedder et al., 1995; Ley et al., 1995) and on the role of 
L-selectin in driving leukocytes to sites of inflammation and infection (Michie et al., 
1993). It is well known that cells are able to cross the endothelium and enter sites of 
inflammation, and those infiltrating cells display a particular phenotype. The CD4-
positive T cells infiltrating the inflamed central nervous system (CNS) express high 
levels of the activation marker CD44, high levels of LFA-1 and are also positive for 
ICAM-1. In addition, CNS infiltrating lymphocytes are negative for L-selectin 
(Engelhardt et al., 1995; Engelhardt et al., 1998). In fact, once lymphocytes are activated, 
L-selectin is down regulated from the cell surface by shedding. L-selectin shedding 
occurs within minutes after lymphocytes activation (Jung et al., 1988) and this is due to 
the cleavage of the extracellular domain of L-selectin proximal to the cell membrane 
(ectodomain) (Kahn et al., 1994; Migaki et al., 1995; Preece et al., 1996; Stoddart et al., 
1996). Several studies focused on L-selectin shedding in order to elucidate the 
mechanisms and the molecules involved. In 1997 a member of the A Disintegrin and 
Metalloprotease family, ADAM17 or TACE (TNF-α converting enzyme) was identified 
as responsible for L-selectin shedding in mouse thymocytes upon PMA (Phorbol 
Myristate Acetate) stimulation (Peschon et al., 1998). In vitro, a role for calmodulin in L-
selectin shedding was demonstrated. Calmodulin binds the cytoplasmic tail of CD62L 
and is released when the intracellular Ca2+ levels increase after cell activation. Loss of 
calmodulin determines a conformational change in L-selectin and allows the cleavage 
molecules to access the ectodomain (Kahn et al., 1998; Fors et al., 2001; Matala et al., 
2001). The function of L-selectin shedding is controversial. In fact it was shown that 
inhibition of shedding has no effect in blocking neutrophil adhesion and transmigration 
under flow (Allport et al., 1997), but another study revealed that blocking L-selectin 
cleavage on lymphocytes results in an increased integrin activation and in a slower 
rolling velocity (Hafezi-Moghadam et al., 2001). 
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I.2. The multi-step cascade for lymphocyte extravasation 
Lymphocytes selectively recognize and adhere to the endothelium in different part of the 
body (Picker et al., 1993). It was shown that HEV are responsible for lymphocyte 
recruitment and extravasation from the blood into peripheral lymph nodes under 
physiological conditions (Streeter et al., 1988; Weisz-Carrington et al., 1991). The 
discovery of adhesion molecules and receptors lead to the conclusion, in the 1980s, that 
there are tissue-specific molecules on the cell surface and lymphocyte migrate in a 
distinct manner in different tissues (Butcher, 1986). Further investigations clarified that 
lymphocyte extravasation is a controlled multistep process, in which adhesion molecules 
and their receptors actively participate (Butcher, 1991; Shimizu et al., 1996; Springer, 
1994). The multi-step cascade for lymphocyte migration into lymph nodes consists of 
four different steps (Figure I.2.1):  
• Tethering and rolling of the lymphocytes along HEV  
• Activation of lymphocyte integrins upon chemokine interaction with their G-protein 
coupled receptors 
• Firm adhesion mediated by integrins  
• Transmigration of activated lymphocytes through the endothelium 
 
 
Tethering and 
Rolling Firm adhesion Transmigration Activation 
basal membrane  
 
L-selectin / α4β7 CCR7 LFA-1 / α4β7
PNAd/MadCAM-1 CCL19, CCL21 ICAM-1/MAdCAM-1 
Paracellular or 
Transcellular 
pathway 
 
Figure I.2.1. The multi-step cascade at peripheral lymph nodes. Circulating lymphocytes bind via L-
selectin or α4β7 integrin their receptors on HEV and reduce their velocity (tethering and rolling). Integrins 
activation is followed by firm adhesion of lymphocytes to the endothelium and subsequent transmigration 
across the endothelium. 
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Tethering and rolling. Tethering and rolling are transient and reversible adhesive 
contacts between lymphocytes and the endothelium. In PLN tethering and rolling is 
mediated by the selectin protein L-selectin and PSGL-1, in Payer’s patches by α4β7 
integrin and MAdCAM-1 (see section I.1).  
 
Activation. Once the cells decrease their velocity and are rolling on HEV, the chemokines 
CCL21 on the high endothelial cells binds its serpentine receptor CCR7 expressed on 
lymphocytes. This interaction starts an inside-out signalling and activates integrins on the 
lymphocyte surface. Integrins are transmembrane glycoproteins responsible for firm 
attachment to the endothelium. Structurally, integrins are heterodimers composed of an 
α-chain of about 120-170kDa and a β-chain of 90-100kDa. The following integrins are 
directly involved in lymphocyte extravasation:  
- α4β1 integrin (VLA-4), which is expressed on lymphocytes, eosinophils and 
monocytes; 
-  α4β7, which is expressed on lymphocytes and mediates, via MAdCAM-1 interaction, 
rolling and adhesion of leukocytes to the mucosal tissues; 
- LFA-1 (lymphocyte function-associated antigen-1) which is expressed on lymphocytes 
and monocytes; 
-  Mac1 (integrin alpha-M), which is exclusively on granulocytes and monocytes. 
The adhesion of lymphocytes to the endothelium is mediated by integrins. Upon 
activation integrins need to change their conformation and form clusters to increase 
affinity and avidity to their specific ligands (Takagi et al., 2002; Hogg et al., 2003; Hogg 
et al., 2004).  
 
Firm adhesion. LFA-1 mediates firm adhesion of lymphocytes to HEV by binding to 
ICAM-1 (Dustin et al., 1998; Von Andrian et al., 1998). In vitro and in vivo, it was 
demonstrated that blocking LFA-1 with antibodies leads to an impairment in lymphocyte 
homing to secondary lymph nodes (PLN and Peyer’s patches). The importance of LFA-1 
in lymphocyte homing to PLN was also demonstrated using LFA-1-deficient mice, where 
in the absence of LFA-1, α4β1 and α4β7 integrins mediate, via VCAM-1 interaction, the 
lymphocyte migration through HEV (Berlin-Rufenach et al., 1999).  
 
Transmigration. After firm adhesion, lymphocytes are ready to migrate across the 
endothelium and cells are driven by chemotactic agents into the lymph nodes. The 
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molecules involved in lymphocyte transmigration at HEV are LFA-1 and ICAM-1. The 
transmigrating lymphocytes cross the endothelium via a paracellular pathway, by which 
cells migrate through the endothelial junctions, or via a transcellular pathway, by which 
cells migrate directly through the endothelium leaving the cell junctions intact. 
 
 
 
 
I.3. The blood-brain barrier 
The blood brain barrier (BBB) is a highly specialized network of tightly connected 
endothelial cells that regulates the flow of cells, nutrients and fluids between the blood 
and the central nervous system. The concept of the BBB was postulated during the 20th 
century. Paul Ehrlich injected some water-soluble dyes intravenously and he detected 
them in all organs but not in the central nervous system (CNS). He did not consider that 
the brain endothelium could be a selective barrier and he concluded that the CNS had no 
affinity for the dyes (Ehrlich, 1904). After a few years, his associate Edwin Goldmann 
repeated the same experiments, but this time the dyes were injected directly into the 
CNS. The dyes stained the CNS and not the other organs, and Goldmann concluded that 
there is a structure within the CNS that is both blood-brain and brain-blood barrier 
(Goldmann, 1913). Only in 1967 Reese and Karnovsky and in 1969 Brightman and 
Reese were able to describe the components of the BBB. A horseradish peroxidase tracer 
was injected into the CNS, or into the blood circulation, and the dye was seen to be 
blocked at the endothelial tight junctions (TJ) of the BBB. The tight junctions consist of 
transmembrane proteins that link together neighbouring endothelial and epithelial cells. 
The tight junctions are responsible for some of the unique characteristics of the barrier 
such as the high electrical resistance of the barrier (1500-2000Ω·cm2) (Crone and Olesen, 
1982). The first protein of the tight junctions identified was occludin (Furuse et al., 
1993). Occludin is an important, but not essential, component of the endothelial tight 
junctions as demonstrated by occludin-deficient mice, which were able to develop fully 
functional tight junctions (Saitou et al., 2000). Essential for the BBB development are 
claudins (Tsukita and Furuse, 1999). The claudin family consists of more than 20 
members. Claudin-5, claudin-12 and claudin-3, which is lost during inflammation (Nitta 
et al., 2003; Wolburg et al., 2003), were shown to be expressed at the tight junction level 
on endothelial cells in the CNS (Wolburg and Lippoldt, 2002; Wolburg et al., 2003). In 
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addition, the junctional adhesion molecules JAM (Martin-Padura, 1998) and the 
endothelial cell-selective adhesion molecule ESAM (Nasdala et al., 2002) were shown to 
be localized at TJ. At the endothelial cell contacts CD99 was detected, a new molecule 
that participates in the migration of lymphocytes to the site of inflammation in vivo 
(Bixel et al., 2004) and of monocytes in vitro (Schenkel et al., 2002). PECAM-1 (platelet 
endothelial cell adhesion molecule-1) is essential for the leukocyte extravasation in vivo 
(Graesser et al., 2002). The endothelial cells are the major cell population at the BBB, 
but the regulation and the functionality of the barrier depends on its interaction with 
astrocytes and pericytes. Astrocytes are cells interacting with the endothelium during 
development and maturation of the BBB. Pericytes are the cells that surround the brain 
capillaries and play an active role in immunity in the brain (Thomas, 1999). Both cells 
types were used during the last years to develop in vitro BBB models, which are useful 
instruments to study molecules and cell types playing a role in lymphocyte trafficking 
across the endothelium. These models were able to reproduce only some of the in vivo 
BBB properties. Recently, a model that retains most of the BBB characteristics has been 
established, showing high electrical resistance, permeability, absence of MECA-32 
expression and up-regulation of cell adhesion molecule ICAM-1 and VCAM-1 upon 
inflammatory stimuli (Coisne et al., 2005). 
 
 
 
 
I.4. Multiple sclerosis and experimental autoimmune encephalomyelitis 
The central nervous system has three peculiarities. First, the blood-brain barrier, with its 
specialized endothelial cells and tight junctions, which clearly separates the CNS 
parenchyma from the blood and prevents blood components from entering the CNS. 
Second, the CNS lacks lymphatic vessels. Third, the major histocompatibility complexes 
(MHC) molecules on parenchymal cells, the antigen presenting cells (APC) and the 
dendritic cells (DC) are absent. Because of these peculiarities, the CNS was for long time 
considered to be an immunoprivileged organ where immunosurveillance is completely 
absent. At present, the CNS is considered to be an immune specialized organ where 
immune cell migration is tightly controlled and regulated (Engelhardt and Ransohoff, 
2005). Sir Peter Medawar was the first person to observe the peculiarity of the CNS. He 
performed tissue transplantations and noticed that tissues implanted into the CNS were 
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rejected after a longer time period compared to the tissues transplanted into other organs 
(Medawar, 1948). Physiologically, the lymphocytes migrating across the BBB into the 
CNS are low in number, but when the integrity of the BBB is disrupted, a massive 
number of cells enters the brain and the spinal cord, starts to damage the CNS and 
induces inflammation. In humans, the disruption of the integrity of the BBB promotes the 
development of multiple sclerosis (MS). MS is a chronic inflammatory progressive 
disease of the central nervous system. It is more common in women than in men and the 
mean onset of disease is between 20-40 years of age. MS is characterized by damage of 
the myelin, the sheath surrounding the nerve fibres in the CNS.  Its aetiology is still 
unknown, but a malfunction of the immune system seems to trigger the disease, as well 
as genetic factors and virus infections in childhood (Sibley, 1985; Poser, 1994). MS 
symptoms are tremor, paralysis and disturbances in coordination, vision and speech. 
Depending on course of the disease, multiple sclerosis is classified in relapsing remitting, 
progressive remitting, primary progressive and secondary progressive which is the most 
severe form of MS. Within the last decades, many investigations have focused on 
possible therapies to modify the course of the disease, exacerbations and to enhance the 
quality of life for patients suffering of MS. Based on findings obtained from animal 
models for MS, several treatments to modify the course of the disease and to reduce the 
exacerbations, such as corticosteroids and IFN-β, have been proposed. The animal 
models used to investigate MS, like experimental autoimmune encephalomyelitis (EAE), 
provide important information for a better understanding of the disease, the cell types and 
the molecules involved and MS progression. EAE has some characteristics resembling 
MS, for example paralysis, demyelination, weakness and incontinence. EAE is an 
autoimmune disease in which inflammatory cells accumulate within the CNS in 
perivascular spaces and form inflammatory cuffs (Levine, 1974). EAE can be induced 
only in susceptible species, such as mice and rats, by active immunization (aEAE) or by 
passive transfer of encephalytogenic T cells (tEAE). The first description of EAE was 
made by Louis Pasteur. In order to develop vaccines against rabies, Pasteur injected 
rabies virus particles from rabbit brains. This vaccination induced neuroparalysis, 
demyelination and death in some of the human recipients who were given the vaccination 
(Pasteur, 1885). The vaccination was modified by Thomas Rivers, who induced 
neurological reactions and immune response in monkeys following multiple injection of 
brain emulsion of rabbits. He concluded that the brain tissue injected, and not the rabies 
virus, has the capacity to trigger CNS disease, demyelination and immune cell infiltration 
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into the CNS  (Rivers et al., 1933). Later on Kabat improved the protocol established by 
Thomas Rivers. Kabat in fact was the first scientist to inject an emulsion of brain and 
complete Freund’s adjuvant in monkeys (Kabat et al., 1947). Further studies 
demonstrated that spinal cord homogenate contains encephalitogenic myelin components 
like MBP (myelin basic protein), MOG (myelin oligodendrocyte glycoprotein) and PLP 
(proteolipid protein), which are able to induce active EAE (aEAE) in susceptible 
recipients (Laatsch et al., 1962; Zamvil et al., 1985; Zamvil et al., 1986; Tuohy et al., 
1989). In 1960, it was demonstrated in rats that T cells can invade the CNS and transfer 
experimental autoimmune encephalomyelitis (tEAE) (Paterson, 1960). Only in 1982, the 
first stable rat T cell line was established and tEAE was induced in syngenic animals 
(Ben-Nun et al., 1982; Ben-Nun et al, 1983). Later on, further investigations 
demonstrated that only freshly activated encephalitogenic T lymphocytes can enter the 
CNS and invade the parenchyma inducing EAE in recipient animals (Wekerle et al., 
1994). 
The lymphocytes entering into the inflamed CNS parenchyma follow a four step cascade 
which resembles the situation at PLN. Encephalitogenic T cells migrating across the 
BBB do not present L-selectin. On the endothelium, E- and P-selectin were demonstrated 
to be absent during inflammation in vivo (Engelhardt et al., 1997). Nevertheless, in vitro 
it could be shown that, upon the induction of inflammation, brain capillary endothelial 
cells express E- and P-selectin on their surfaces (Coisne et al., 2006). In addition, 
circulating lymphocytes were observed to be captured, and not rolling on the 
endothelium, via the interaction between α4-integrin and VCAM-1 by intravital 
microscopy at spinal cord (Vajkoczy et al., 2001). It was also shown that during CNS 
inflammation, chemokines and G-protein mediated signals are required to promote T cell 
adhesion on the BBB. In addition, it was demonstrated that the chemokines CCL19 and 
CCL21 on the endothelium are involved in T cell adhesion to the inflamed BBB. In fact, 
by means of in situ hybridization, it was demonstrated that CCL19 and CC21 are present 
on the vessels surrounded by inflammatory cells (Alt et al., 2002). The molecules mainly 
involved in lymphocyte transmigration are ICAM-1 and VCAM-1. Antibodies against 
ICAM-1 were able to reduce inflammation in many animal models (Carlos et al., 1994) 
and the cytoplasmic tail of ICAM-1 was demonstrated to be essential for the lymphocyte 
transmigration in vitro (Greenwood et al., 2003; Lyck et al., 2003). There are two 
theories regarding the pathway used by the lymphocytes to transmigrate. On the one side 
there is evidence supporting the paracellular pathway, by which cells migrate through the 
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endothelial junctions. If cells use this pathway to cross the endothelium, a rearrangement 
of the junction proteins and their ligands is required. On the other hand, there is also 
evidence for the transcellular pathway, by which cells migrate through the endothelium 
leaving the tight junctions intact (Engelhardt and Wolburg., 2004). Electron microscopy 
studies on murine inflamed CNS sections demonstrated that the endothelial cells extend 
some protrusions on the luminal site and embrace the migrating cell. The abluminal site 
of the protrusion is then surrounded with basal lamina and the cell membrane changes its 
characteristics (Wolburg et al., 2005). At the end of the migration, the cell is released on 
the abluminal site of the endothelium and can invade the CNS parenchyma. 
 
The molecules involved in the multistep cascade for lymphocyte migration are not yet 
completely identified. In fact focusing on all the steps here described, there still many 
investigations are required to identify possible new adhesion molecules involved in the 
diapedesis of lymphocytes across the endothelium. At the same time, there are still many 
investigations which focus on already known molecules, to better characterize their role 
in the transmigration of lymphocytes through the endothelium. 
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AIM OF THE STUDY 
 
The aim of this study was to investigate the role of L-selectin in the recruitment of 
inflammatory cells across the blood-brain barrier (BBB) and in the immunopathogenesis 
of experimental autoimmune encephalomyelitis (EAE). To evaluate the role of L-selectin 
in EAE in SJL mice, SJL/L-selectin-deficient mice were generated by backcrossing the 
original L-selectin-deficient strain into the EAE susceptible SJL background and the 
phenotype of SJL/L-sel-/- mice was investigated. To study the role of L-selectin during 
the recruitment of inflammatory cells into the CNS, EAE was induced in SJL wt and 
SJL/L-sel-/- mice by active immunization (aEAE) with a single injection of proteolipid 
protein (PLP aa139-151) emulsified in complete Freund’s adjuvant (CFA). To test the 
ability of SJL/L-selectin-deficient and SJL wild type PLP-specific T cells to transfer the 
disease in syngenic recipients, EAE was induced by passive transfer of in vitro activated 
T cell blasts (tEAE). The presence of CD45-positive inflammatory cells within the CNS 
was detected by immunohistochemistry.  
To characterize the phenotype of SJL wild type and SJL/L-sel-/- naïve and 
effector/memory T cells, the presence of cell surface molecules such as integrins 
involved in lymphocyte adhesion and transmigration, and PSGL-1, which is involved in 
lymphocyte rolling, were investigated by flow cytometry. In addition, the presence of 
cytokine receptors (IL-2 receptor) and the presence of costimulatory molecules (CD28, 
CD152 and CD154), which are involved in cell proliferation, were investigated and were 
compared in SJL wt versus SJL/L-selectin-deficient T cells. 
Finally, the migration efficiency of SJL/L-selectin-deficient T cells across an 
endothelium was investigated in a functional in vitro assay (Trans-Endothelial Migration) 
and compared to SJL wild type T cells. 
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II. MATERIALS AND METHODS 
 
II.1.Devices and materials 
Here is a list of devices and materials used. 
 
Devices  
β-scintillation counter Beckman-Coulter; Krefeld, Germany 
Cell Harvester     Inotech; Dottikon, Switzerland 
CO2 Incubator IR Autoflow   Nuaire; Fermald, Switzerland 
Digital Camera DMX1200F   Nikon; Egg, Switzerland 
Gel chamber Sub-Cell GT   Bio-Rad; Munich, Germany 
Heating Block Thermomixer   Eppendorf; Hamburg, Germany 
Laminar flow cabinet    Nuaire; Fermald, Switzerland 
Magnetic stirrer    IKA-WERKE; Staufen, Germany 
MasterCycler     Eppendorf; Hamburg, Germany 
Microscope Axiovert 25   Zeiss; Feldbach, Switzerland 
Microscope Eclipse E600   Nikon; Egg, Switzerland 
Microtome HM 550 OM   Microm; Walldorf, Germany 
Multiple pipet     Eppendorf; Hamburg, Germany 
Nikon microscope and camera   Nikon; Egg, Switzerland 
Pipetboy acu     Integra Bioscience; Fernwald, Germany 
PCR reaction machine    Eppendorf; Hamburg Germany 
Vortex Genie     Scientific Industries; Bohemia, NJ, USA 
Water bath     Julabo; Seebach, Germany 
 
Expendable materials 
Cell culture vented cap flasks  Greiner bio-one; Nürtingen, Germany 
Cell culture Petri dishes   BD Falcon, Heidelberg, Germany 
15ml , 50ml polypropylene tubes  BD Falcon; Heidelberg, Germany 
0.22µm pore size 45mm diameter filters Millipore; Volketswil, Switzerland 
0.22µm pore size syringe filters  Pall; Dreiech, Germany 
 16
                                                                                                                            Materials and Methods 
Reaction tubes 1.5ml, 2ml  Eppendorf; Hamburg, Germany 
Pipette tips  Greiner bio-one; Nürtingen, Germany 
Cryotubes 1.5ml  Greiner bio-one; Nürtingen, Germany 
10µl, 200µl, 1000µl pipettes  Gilson; Middleton, WI, USA 
PCR reaction tubes  Greiner bio-one; Nürtingen, Germany 
 
Serum 
Foetal bovine serum  PAN Biotech; Aidenbach, Germany 
Foetal bovine serum  BioWest; Nuaillé, France 
Newborn calf serum    Gibco; Karlsruhe, Gemany 
Calf serum     PAA; Cölbe, Germany 
Normal mouse serum    Serotec; Düsseldorf, Germany 
Normal rat serum    Serotec; Düsseldorf, Germany 
Goat serum     Serotec; Düsseldorf, Germany 
Rabbit serum     Serotec; Düsseldorf, Germany 
 
 
 
Cell culture media 
RPMI 1640, DMEM (Dulbecco’s Modified Eagle Medium) 4500g/l glucose, HBSS 
(Hanks’ Balanced Salt Solution) and PBS (phosphate buffer solution) were 
purchased from Invitrogen (Basel, Switzerland) 
 
Cell culture media supplements 
HEPES, L-glutamine, Penicillin/Streptomycin, non-essential amino acids, Na-
Pyruvate, Concanavalin A, Trypan blue 0.4% and Trypsin/EDTA solution were 
purchased from Invitrogen (Basel, Switzerland) 
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II.2. Tissue culture media 
 
All media, sera and supplements used were filtered using a 0.22µm pore size sterile 
filter (Millipore AG, Volketswil, Switzerland). Cell lines were maintained at 37°C, 
5-10% CO2 and 100% humidity in sterile conditions in CO2 incubators (Nuaire, 
Fermwald, Switzerland). Cells were cultivated in sterile Petri dishes (BD Falcon; 
Heidelberg, Germany) or vented-cap flasks (Greiner bio-one; Nürtingen, Germany). 
 
Preparation of culture media for T cell lines: IL-2 containing TCGF medium and 
Restimulation medium 
T cells were cultured in T cell growth factor (TCGF) medium, which is composed 
by RPMI 1640 supplemented with 10% foetal serum (PAN Biotech), 4mM L-
Glutamine, 1mM Na-Pyruvate, 100U/ml Penicillin, 100µg/ml Streptomicyn, 1% 
MEM non-essential amino acids (100x), 0.05mM β-Mercaptoethanol and 
Concanavalin A supernatant. 
T cells were restimulated in RPMI 1640 supplemented with 10% foetal serum, 4mM 
L-Glutamine, 1mM Na-Pyruvate, 100U/ml Penicillin, 100µg/ml Streptomycin, 1% 
MEM non-essential amino acids (100x), 0.05mM β-mercaptoethanol (Restimulation 
medium). 
 
Preparation of endothelioma medium 
Endothelioma cells (bEnd.5) were cultured in DMEM supplemented with 10% 
foetal bovine serum (BioWest), 4mM L-Glutamine, 1mM Na-pyruvate, 100U/ml 
Penicillin, 100µg/ml Streptomycin, 1% MEM non-essential amino acids (100x), 
0.05mM β-Mercaptoethanol. 
 
Preparation of migration assay medium (MAM) 
Transmigration and adhesion assay were performed in DMEM supplemented with 
5% calf serum, 4mM L-Glutamine and 25mM HEPES 
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Preparation of washing buffer 
Complete washing buffer was prepared with 10% FCS and 25mM HEPES in HBSS. 
Incomplete buffer, used during density gradient and ConcanavalinA supernatant 
preparation, was supplemented only with 25mM HEPES 
 
Preparation of Concanavalin- A medium 
Splenocytes of C3H mice (Harlan Nederlands; Horst, Netherland) were 
homogenized, resuspended and cultured overnight in DMEM low-glucose 
supplemented with 1% normal mouse serum (Serotec), 4mM L-Glutamine, 1mM 
Na-Pyruvate, 100U/mL Penicillin, 100µg/mL Streptomyicin and 1% MEM non-
essential amino acids (100x) and 5g Concanavalin A powder (Sigma Aldrich; Basel, 
Switzerland). 
 
 
 
 
II.3. T cell lines 
 
Here are the protocols regarding T cell lines: preparation of primary PLP139-151 
specific CD4-positive T cell lines, isolation of PLP-specific blasts, restimulation of 
resting cells using their respective antigen, freezing and thawing. Cells were 
cultured in sterile conditions in Nuaire incubators at 37°C, 7% CO2, 100% humidity 
in Petri dishes (PD).  
 
Preparation of primary PLP139-151 specific T cell lines 
PLP-specific T cell lines were obtained from SJL wild-type (Taconic; Ry, Denmark) 
and SJL/L-selectin-deficient mice bred in our own animal facility according to the 
requirements of the local government. Mice were immunized with 50µg/ml of  
PLP139-151 (H2N-H-C-L-G-K-W-L-G-H-P-D-K-F-COOH) (ThermoHybaid; Ulm, 
Germany) dissolved in PBS and emulsified in complete Freund’s adjuvant (CFA; 
Santa Cruz Biotechnology; Santa Cruz, CA, USA). CFA was prepared adding to the 
incomplete Freund’s adjuvant 4mg/ml heat-inactivated Mycobacterium tuberculosis 
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micro-organisms. PLP139-151 and PBS and CFA were mixed and 100µl of this 
emulsion were subcutaneously injected in flanks and tail root of anaesthetized mice. 
At 10-14 days post immunization, mice were sacrificed by cervical dislocation and 
their spleens were dissected in sterile conditions. Spleens were cut into small pieces, 
suspended in complete washing buffer and homogenized with a pestle (Wheaton; 
Millville, NJ, USA). Cell suspension was then filtered through a 100µm pore size 
nylon mesh and centrifuged (RT, 1200rpm, 10 min). The supernatant was removed, 
the pellet was filtered once again and the cells were counted. This assay was 
performed in 60mm PD containing 5ml of Restimulation medium supplemented 
with 10µg/ml PLP139-151 antigen. After three days, 1ml TCGF medium was added to 
the culture and after 16 hours T cell blasts were isolated by density gradient and 
cultured in IL-2 containing medium (TCGF). 
 
• Immunization of mice using an emulsion of CFA, PBS and PLP139-151 
• After 10-14 days, mice are sacrificed  and spleens are dissected in sterile conditions 
• Spleens are homogenized, filtered and splenocytes are counted 
• 5·107 splenocytes are plated in 60mm PD in 5ml Restimulation medium containing 10µg/ml 
PLP139-151 antigen  
• After 3 days, 1mL TCGF medium is added to the culture 
• After 16h, activated blasts are isolated by density gradient 
 
Table II.3.1. Preparation of primary PLP-specific T cell lines.  
 
 
 
T cell blasts isolation by density gradient  
T cell blasts, highly activated against their specific antigen PLPP139-151, were isolated 
by density gradient and separated from debris and unspecific cells. Cells from two 
60mm PD were collected, washed with complete washing buffer and centrifuged 
(RT, 1200rpm, 10 min). Pellet was resuspended in 3ml incomplete washing buffer 
(HBSS and 25mM HEPES) and this suspension was placed carefully on the top of 
5ml NycoPrep 1.077A solution (Axis-Shield; Oslo, Norway), at room temperature, 
in a 15ml polystyrene tube (BD Falcon; Heidelberg, Germany) and centrifuged 
(1300rpm, 20min, without brake). At the end of centrifugation, T cell blasts formed 
a layer between the supernatant and NycoPrep solution. Blasts were collected and 
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washed 3 times in complete washing buffer, thus counted and plated (2-3·106 cells / 
100mm PD in 10ml TCGF medium) or used for experiments. 
 
• Cells from two 60mm PD are collected and centrifuged 
• Pellet is resuspended in 3ml washing buffer and cells are added on the top of 5ml NycoPrep 
1.077A solution at RT in 15ml polypropylene tubes 
• After centrifugation, T cell blasts are collected  and washed three times with washing buffer 
• Cells are then counted and plated in 100mm PD or used for experiments 
 
Table II.3.2. T cell blasts isolation by density gradient. 
 
 
 
 
Restimulation of PLP-specific T cell lines 
T cells were cultured in TCGF medium for 5-8 days and checked daily under a 
microscope to evaluate their status. Freshly activated blasts were large and exhibited 
a tennis racket shape, resting cells were small and round. When cells reached the 
resting phase, they had to be restimulated in order to maintain them in culture and to 
keep them available for further use. To restimulate PLP-specific T cell lines it is 
necessary to co-culture those cells together with splenocytes and PLP139-151 antigen. 
Splenocytes were used as antigen presenting cells (APC) and came from 8-12 weeks 
old females of SJL mice. Mice were sacrificed by cervical dislocation, spleens were 
dissected, homogenized, filtered and centrifuged (RT, 1200rpm, 10 min). After 
centrifugation, pellet was resuspended in complete washing buffer and cells were 
irradiated (45Gy at University Hospital Münster, Germany and University Hospital 
InselSpital, Bern, Switzerland) to obtain a suspension of living but not replicating 
cells. Therefore, splenocytes were filtered again through a nylon mesh (100µm pore 
size), centrifuged, counted and plated in a 60mm PD, together with 1.5-2·106 resting 
lymphocytes in 5ml Restimulation medium containing 10μg/ml PLP139-151 antigen. 
After two days, 1ml TCGF medium was added to the culture and after 16 hours 
activated T cell blasts were separated by density gradient. 
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• 8-12 weeks old syngenic mice are sacrificed and spleens are dissected under sterile conditions 
• Spleens are homogenized, filtered and sublethally irradiated 
• Splenocytes are filtered again, centrifuged and counted 
• 4·107 splenocytes are plated together with 1.5-2·106 resting lymphocytes in 5ml Restimulation 
medium containing 10µg/ml PLP139-151 antigen 
• After 2 days, 1ml TCGF is added to the culture 
• After 16h, T cell blasts are separated by density gradient 
 
Table II.3.3. Restimulation of PLP-specific T cell lines. 
 
 
Antigen specificity assay 
To detect the specificity of T cells for their specific antigen PLP139-151, in parallel 
with restimulation a specificity assay was performed. In each well of a 96 well-plate 
U shaped bottom (Greiner bio-one), 2·104 resting lymphocytes were co-cultured 
with 5·105 irradiated splenocytes. To the cell medium were supplemented the 
specific antigen PLP139-151 (10µg/ml), the unspecific antigen purified protein derivate 
(PPD) from Mycobacterium tuberculosis (10µg/ml), the mitogenic factor 
Concanavalin A (2.5µg/ml) as positive control and no antigen as negative control. 
Samples were plated in triplicate. After two days, 1µCi 3H-thymidin (3H-dT) 
(Amersham Pharmacia, Otelfingen, Switzerland) was added to the culture and after 
16 hours the specificity of T cell lines was determined by measuring the 
incorporation of the radioactive tracer 3H-thymidine. Cells were aspirated by a cell 
harvester machine (Inotech; Dottikon, Switzerland), locked in a glass fibre filter 
(Inotech; Dottikon, Switzerland) and after that lysed with ddH2O. The radioactivity 
incorporated in proliferating cells was then measured by a β-scintillation counter 
(Beckman-Coulter).  
 
• 2·104 resting lymphocytes are co-cultured, in triplicates, with 5·105 irradiated splenocytes in a 
96 well-plate U shaped bottom 
• PLP139-151 (10µg/ml), the unspecific antigen purified protein derivate (PPD) (10µg/ml), the 
mitogenic factor Concanavalin A (2.5µg/ml) as positive control and no antigen are added to the 
cells in culture 
• After 2 days, 1µCi 3H-thymidin is added and 16h after that cells are aspirated by a cell harvester 
machine and release radioactivity in a glass fibre filter 
• Proliferation and specificity are measured by a beta-counter machine 
 
Table II.3.4. Antigen specificity assay 
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Freezing and thawing of T cells 
In order to freeze T cells, they were collected from 2-5 100mm PD, centrifuged (RT, 
1200rpm, 10min) and suspended in 1.5ml freezing medium composed of RPMI 
1640, 50% FCS and 10% DMSO. The cell suspension was placed in cryotubes 
(Greiner bio-one) and slowly cooled down to -80°C. After 2-3 days, cells were 
transferred into a liquid nitrogen tank. To thaw cells, T lymphocytes were rapidly 
taken at RT, resuspended in complete washing buffer, centrifuged and plated in 
culture dishes in TCGF medium or used for restimulation assays. 
 
Freezing of T cells 
• Cells are collected and centrifuged 
• Pellet is resuspended in 1.5ml freezing 
medium 
• Cells are pipetted  into cryotubes  
• Cells are frozen at -80°C 
• After 2 days, cells are transferred into a 
liquid nitrogen tank 
Thawing of T cells 
• Cells are thawed at 37° 
•  Cells are resuspended in washing buffer 
and centrifuged 
• Pellet is resuspended  in medium 
 
Table II.3.5. Freezing and thawing of T cell lines 
 
 
 
IL-2 containing Concanavalin A supernatant 
To prepare IL-2 containing Concanavalin A supernatant (ConAS), spleens from 8-
10 week old C3H mice (Harlan Nederlands; Horst, Nederland) were dissected and 
homogenized, then filtered through 100µm nylon mesh and centrifuged (RT, 
1200rpm, 10min). Pellet was resuspended in ConcanavalinA medium and 107 
cells/ml were plated in 10ml in 100mm PD and incubated 24h at 37°C and 7% CO2. 
After incubation, supernatant was collected and aliquots of 45ml were stored at -
20°C in sterile tubes. To determine the appropriate concentration of ConAS within 
the TCGF medium, 1·104 cells/100µl per well were plated in triplicates in a 96 well-
plate U-shaped bottom. The proliferation of those cells in presence of different 
ConAS dilutions (50%, 25%, 12.5%, 6.25%, 3.125%, no Concanavalin A 
supernatant) was assessed by 3H-dT incorporation: cells were incubated and after 3 
days 1µCi of 3H-thymidine was added. 16h after that, cells were harvested and 
radioactivity incorporation was measured with a β-scintillation counter. 
 23
                                                                                                                            Materials and Methods 
Preparation of Concanavalin A supernatant (ConAS) 
• Spleens were dissected from C3H mice, homogenized, filtered and centrifuged 
• Pellet was resuspended in Concanavalin A medium and 107cells/ml plated in PD 
• Cells were incubated 24h 
• Supernatant was collected and 45ml aliquots stored at -20°C 
ConAS test 
• 1·104cells/100µl were plated in triplicates in a 96 well-plate U-shaped bottom 
• Dilutions of 50%, 25%, 12.5%, 6.25%, 3.125% and no ConAS were added to the culture 
• After 3 days, 1μCi of 3H-thymidine was added 
• After 16h, cells were harvested and proliferation was measured to determine which 
concentration ConAS should be used to prepare TCGF medium 
 
Table II.3.6. IL-2 containing Concanavalin A supernatant 
 
 
 
 
 
 
 
II.4. Animal models 
 
To investigate the role of L-selectin in the pathogenesis of experimental 
autoimmune encephalomyelitis (EAE), it was necessary to induce the disease in SJL 
wild-type and SJL/L-selectin-deficient mice. Here are presented the protocols used 
to induce active (aEAE) or passively transfer (tEAE) experimental autoimmune 
encephalomyelitis. 
 
 
Breeding and backcrossing of L-selectin-deficient mice into SJL  background 
L-selectin-deficient mice were generated (Catalina et al., 1996) and provided by 
Prof.Dr. Siegelman (Southwestern Medical Centre, University of Texas – USA). 
Mice were backcrossed into the SJL background because this strain is susceptible to 
experimental autoimmune encephalomyelitis. The first generation was obtained 
breeding L-selectin-deficient mice and SJL wild type mice. The generated 
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heterozygous mice were then backcrossed with wild type SJL animals until 
generation F8. At this time, heterozygous mice were bred to generate SJL/L-
selectin-deficient mice. Mice between backcrossing generation F8 and F18 were 
used during this study. The genotype of the animals was detected by PCR  (see 
section II.8). 
 
Active experimental autoimmune encephalomyelitis (aEAE) 
As has already been described (Engelhardt 1997 and Engelhardt and Laschinger 
1998), anaesthetised mice were immunized by injecting subcutaneous in the tail root 
and flanks - 50µg/ml PLP139-151 emulsified in PBS and CFA. At day 1 and 3 post 
immunization, 3·109 Bordetella pertussis heat-inactivated organisms were injected 
intravenously in the tail. Daily, weight and clinical score were controlled in order to 
monitor signs and ongoing of disease. Disease started after around 10 days and 
clinical symptoms were scored as: 
0  healthy 
0.5 limp tail 
1  hind leg weakness 
2  hind leg paralysis 
3  hind leg paraparesis and incontinence 
4  death 
 
 
 
Figure II.4.1. Healthy SJL mouse, clinical score 0. EAE symptoms are dot detectable. 
 
 25
                                                                                                                            Materials and Methods 
 
Figure II.4.2. EAE affected SJL mouse, clinical score 2, hind leg paralysis. 
 
 
Passive transfer of experimental autoimmune encephalomyelitis (tEAE) 
Freshly activated PLP-specific T cell blasts were injected in syngenic mice to test 
their encephalitogenicity. 3·106 blasts of established T cell lines or 2·107 primary 
blasts were diluted in PBS and injected intravenously in 8-12 week old mice. The 
disease started 7-14 days after injection and clinical symptoms were scored as for 
aEAE. 
 
Animal perfusion and tissue freezing 
To evaluate whether injected blasts were encephalitogenic and if CD45 positive 
cells infiltrated the CNS, tissues from EAE affected mice and healthy control 
animals were prepared and snap frozen. Mice were first anaesthetised with 
isoflurane (CuraMed; Karlsruhe, Germany) and then perfused with freshly prepared 
and cold 1% (w/v) PFA/PBS to remove blood and fix infiltrating cells. At this time 
brain and spinal cord were dissected, cut in pieces and snap frozen in Tissue-Tek 
O.C.T. compound (Sakura Finetek; Giessen, Germany) in cryomolds (Miles Inc.; 
Giessen, Germany). The cryomolds were frozen in a solution of 2Methyl-butan and 
dry ice and afterwards stored at -80°C. To prepare cryosections of the CNS, tissues 
were removed from their location at -80°C and placed at -20°C for around 30min 
before mounting them on a blockholder in a microtome (Microm). 6µm tissue 
sections were cut and mounted on silanized slides (Vogel; Giessen, Germany). 
Samples were dried overnight at RT, fixed in acetone at -20°C for 10min and dried 
again at RT at least 30min. Slides were ready for analysis (see section II.7) or were 
frozen at -20°C in presence of silica gel (Carl Roth; Karlsruhe, Germany).  
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II.5. Endothelioma cell line 
 
The brain endothelioma cell line bEnd5 was prepared from brain microvessels of 
BALB/c mice and immortalized using Polyoma middle-T (pymT) oncogene 
expression (Kiefer et al., 1994; Wagner and Risau, 1994 ). Because of their adhesion 
molecule expression pattern (Reiss et al., 1998), bEnd5 cells are considered to be a 
wild-type endothelial cell line. 
Here are reported the protocols regarding culture and freezing and thawing of the 
endothelioma cell line bEnd5. 
 
Culture of endothelioma cell line bEnd5 
bEnd5 cells were cultured in vented cap flasks (Greiner Bio-One) at 37°C and 10% 
CO2 in sterile conditions. Cells were fed twice per week and reached confluency in 
4-5 days. Cells were split after 10 days by trypsinization. In order to passage them, 
cells first have to be washed 5min with PBS/5mM EDTA and then detached by 
incubating them at 37°C with 0.05% Trypsin/EDTA (Invitrogen). After 5min, cells 
are washed with washing buffer, collected and centrifuged (RT, 1200rpm, 10min) 
and then plated again in a 1:4 dilution or used for experiments. 
 
• bEnd5 cells are washed with PBS/EDTA 5mM  
• PBS is removed and cells are digested with 0.05% Trypsin/EDTA 
• Cells are washed to remove Trypsin, collected and centrifuged 
• Cells are plated with endothelioma medium in dilution 1:4 or used for experiments 
 
Table II.5.1. Culture of bEnd5 cells 
 
 
 
Freezing and thawing of bEnd.5 cell lines 
Confluent cells were trypsinized as described above. Pellet was resuspended in 
freezing medium (DMEM, 30% FCS, 10% DMSO) and cooled down at -80°C in 
cryotubes. After 2-3 days cryotubes were moved into a liquid nitrogen tank. Cells 
were rapidly warmed up to thaw them and washed in washing buffer, centrifuged 
and plated in endothelioma medium.  
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Freezing of bEnd5 cells 
• Confluent cells are washed with 
PBS/EDTA 
• Cells are digested with Trypsin/EDTA 
• Cells are resuspended in washing 
buffer and centrifuged 
• Pellet is resuspended in freezing 
medium 
• Cells are put in cryotubes and those 
were cooled down at -80°C 
• After 2-3 days, cryotubes are moved 
into a liquid nitrogen tank 
Thawing of bEnd5 cells 
• Cryotubes are rapidly warmed up at 37°C 
• Cells are resuspended in Washi buffer and  
centrifuged 
• Pellet is resuspended in endothelioma 
medium and cells plated in flasks or used for 
experiments 
 
Table II.5.2. Freezing and thawing of bEnd5 cells 
 
 
 
 
II.6. In vitro Trans-Endothelial Migration assay (TEM) 
 
The trans-endothelial migration (TEM) assay is a highly reproducible in vitro assay 
that allows us to study leukocyte migration across an endothelium and molecules 
involved in this pathway. The protocol presented here has been extensively 
described in Leukocyte trafficking - molecular mechanisms, therapeutic targets and 
methods (Chapter 19, Alf Hamann and Britta Engelhardt Editors, Wiley-VCH). 
 
 
Figure II.6.1. Trans-Endothelial Migration 
 
 28
                                                                                                                            Materials and Methods 
During the first day, endothelial cells (bEnd5) were plated on laminin coated 
Transwell® culture inserts of 6.5mm diameter and 5µm pore size (Costar; 
Cambridge, MA, USA). Filters were coated with 50µg/ml laminin (Roche; Basel, 
Switzerland) to permit the endothelial cells to form a confluent monolayer. 50µl 
laminin were incubated for 30min on each insert, then aspirated and dried 1-2h at 
RT under laminar flow. bEnd5 cells were trypsinized (see Culture of endothelioma 
cell line bEnd5 section) and 5·104 cells were plated in 200µl of endothelial medium 
each filter. Medium was added only into the upper chamber to prevent non 
physiological sprout formation through the pores in the lower chamber. After 48h, 
bEnd5 cells were treated with 5nM TNF-α, a proinflammatory cytokine inducing 
breakdown of the monolayer, and incubated for 16h. The day after, filters were 
washed twice with 200µl migration assay medium -MAM- (DMEM, 5% calf serum, 
4mM L-Glutamine and 25mM HEPES) and incubated with antibodies 30min. At the 
same time, also T cells were incubated at 37°C with antibodies in order to 
investigate molecules involved in transmigration of leukocytes across the 
endothelium. After the incubation time expires, cells were washed to remove excess 
of antibodies and 105 T cells in100µl MAM medium were pipetted in the upper 
chamber. 600µl MAM were added into the lower chamber and the assay was 
running for 3-4h in a humidified environment at 37°C and 10% CO2. At the end of 
this incubation time, 500µl MAM and migrated cells from the lower chamber were 
added to 9.5m filtered CASY®  cell counting buffer into CASY® tubes and analysed 
with CASY® cell counter (Schärfe System; Reutlingen, Germany). Data, in 
triplicates, were given as percentage of migrated cells (mean value and standard 
deviation). To asses the status of the endothelium, filters were washed in PBS, fixed 
in a formalin saturated chamber for 1-2h and stained with 5% (v/v in tap water) 
Giemsa’s azure eosin methylene blue solution (Merck) for 10min. Dyes in excess 
was removed by aspiration and filters were dried overnight. The day after, filters 
were mounted with Entellan (Merck) on glass slides and checked at microscope. 
Migration values from damaged or not confluent monolayers were excluded from 
the assay. 
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Day 1 
• Transwell® filters are coated with 50µg/ml laminin for 30min 
• Laminin is aspirate and filters let dry at RT 1-2h 
• 5·104 endothelial cells are plated in 200µl endothelial medium each insert 
Day 2 
• Endothelial cells are treated with 5nM TNF-α 16h 
Day 3 
• Endothelial and T cells are incubated 30min with antibodies 
• Antibodies are washed away with MAM medium  
• 105 T cells are pipetted into the upper chamber on the top of the bEnd.5 monolayer 
• 600µl MAM are pipetted into the lower chamber 
• Assay is started in a humidified incubator at 37°C and 10% CO2  
• After 3-4h, 500µl medium and migrated cells are collected from the lower chamber and pipetted 
into a CASY® tube containing 9.5ml CASY® cell counting buffer 
• Samples are analyzed at CASY® cell counter and given as percentage of migrated cells across the 
endothelium 
• Filters are washed in PBS, fixed with gaseous formalin 1-2h and stained with 5% Giemsa’s azure 
solution 10min 
• Filters are dried overnight 
Day 4 
• Filters are  mounted with Entellan on glass slides and analysed at microscope 
• Values coming from damaged or not confluent monolayers are excluded from the assay 
 
 
Table II.6.1.  Trans Endothelial Migration assay (TEM) 
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II.7. Immunofluorescence 
  
Immunofluorescence techniques were applied to living cells or to frozen tissue 
sections to detect surface molecules expression (Flow cytometry) or to detect the 
presence of infiltrating cells into the CNS (Immunohistochemistry). The following 
protocols and antibodies were used. 
 
Tissue culture supernatants 
Tissue culture supernatants were prepared from rat anti-mouse hybridoma cells and 
used directly or as purified monoclonal antibodies. Supernatants were prepared in 
our laboratory as described in the PhD thesis of Dr.Melanie Laschinger (2002) and 
the presence of endotoxins was tested at the Fresenius Laboratories in Berlin 
(Germany).  
 
Antibody Antigen Isotype Source Reference 
9B5 
Human CD44, 
negative 
control 
IgG2a 
E.Butcher, Stanford, CA, 
USA 
Jalkanen et al., 1986 
Mec 13.3 PECAM-1 IgG2a 
ATCC, Rockville, MD, 
USA 
Vecchi et al., 1994 
Mel 14 L-selectin IgG2a 
E.Butcher, Stanford, CA, 
USA 
Gallatin et al., 1983 
GK 1.5 CD4 IgG2b 
ATCC, Rockville, MD, 
USA 
Wilde et al., 1983 
M1/9 CD45 IgG 
ATCC, Rockville, MD, 
USA 
Springer et al., 1978 
PS/2 α4 integrin IgG2b P.Kincade, Oklahoma 
City, OK, USA 
Miyake et al., 1991 
9EG7 β1 integrin IgG2a D.Vestweber, Münster, 
Germany 
Lenter et al., 1993 
DATK 32 α4β7 integrin IgG2a E.Butcher, Stanford, CA, 
USA 
Andrew et al., 1994 
Fib 504 β7 integrin IgG2a E.Butcher, Stanford, CA, 
USA 
Andrew et al., 1994 
FD441.8 LFA-1 IgG2b 
ATCC, Rockville, MD, 
USA 
ATCC, Rockville, MD, 
USA 
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25ZC7 ICAM-1 IgG2a 
D.Vestweber, Münster, 
Germany 
Steffen et al., 1996 
30H12 
FITC 
Thy1.2 IgG2b 
BD Pharmingen, 
Heidelberg, Germany 
Ledbetter et al., 1979 
B220 
FITC 
CD45R IgG2a 
BD Pharmingen, 
Heidelberg, Germany 
Coffman et al., 1982 
Gr-1 FITC 
Ly6G and 
Ly6C 
IgG2b 
BD Pharmingen, 
Heidelberg, Germany 
Malek et al., 1993 
M1/70 
FITC 
CD11b IgG2b 
BD Pharmingen, 
Heidelberg, Germany 
Springer et al., 1983 
4RA10 PSGL-1 IgG1 
D.Vestweber, Münster, 
Germany 
Frenette et al., 2000 
23G2 CD45RB IgG2a 
D.Vestweber, Münster, 
Germany 
Lee et al., 1990 
7D4 CD25 IgM 
BD Pharmingen, 
Heidelberg, Germany 
Malek et al., 1983 
PC61 CD25 IgG1 
BD Pharmingen, 
Heidelberg, Germany 
Moreau et al., 1987 
3C7 CD25 IgG2b 
BD Pharmingen, 
Heidelberg, Germany 
Ortega et al., 1984 
TMβ1 CD122 IgG2b BD Pharmingen, 
Heidelberg, Germany 
Tanaka et al., 1991 
5H4 CD122 IgG2a 
BD Pharmingen, 
Heidelberg, Germany 
Furse et al., 1993 
TUGm2 CD132 IgG2b 
BD Pharmingen, 
Heidelberg, Germany 
Guesdon et al., 1979 
4G3 CD132 IgG2a 
BD Pharmingen, 
Heidelberg, Germany 
Gillis et al., 1978 
F4/80 
FITC 
F4/80 IgG2b 
Serotec, Dusseldorf, 
Germany 
Gordon et al., 1981 
 
Table II.7.1. List of antibodies used to detect cell surface molecules 
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Flow cytometry 
Flow cytometry was used to analyse the phenotype of T cells or naïve lymphocytes. 
Cell surface molecule expression, detected using antibodies (see Table II.7.1), was 
compared in different cell lines and at different stages of activation, as well as in 
primary naïve lymphocytes from different organs (spleen, peripheral lymph nodes 
PLN, mesenteric lymph nodes MLN) and different mouse strains (SJL wild-type, 
SJL/L-selectin-deficient and L-selectin-deficient mice). Cells in culture were 
collected, centrifuged and resuspended in FACS buffer (PBS, 2.5% Calf serum, 
0.01% NaN3) to obtain a cell suspension of 105 cells/well in a 96 well-plate U-
shaped bottom. Naïve lymphocytes were obtained by sacrificing mice and dissecting 
organs of interest. Those were afterwards homogenized, filtered, centrifuged, 
counted and diluted. Plates were centrifuged (4°C, 1400rpm, 4min), supernatant was 
removed and, working on ice, incubated 30min with the first antibody (100µl/well). 
The first primary antibodies were either hybridoma cell supernatant produced in our 
laboratory or purified antibodies at the concentration of 10µg/ml in PBS. At the end 
of incubation time, cells were washed twice using FACS buffer and centrifuged 
(4°C, 1400rpm, 4min). Working in dark and on ice, cells were incubated with 
10µg/ml phycoerythrin (PE)-conjugated goat anti-rat IgG antibody (Jackson Labs; 
Dianova, Hamburg, Germany), previously neutralized with 10% normal mouse 
serum to prevent unspecific bindings. After 30min, cells were washed and 
centrifuged twice, then incubated 10min with 10% rat serum - 10µl/well (Serotec). 
Cells were then ready to be incubated 30min with the antibody Thy1.2-FITC 
(fluorescein isotiocyanate) (CD90.2) (Pharmingen; Heidelberg, Germany), specific 
for lymphocytes detection. Cells were washed and fixed in 1% (w/v) PFA/PBS and 
analysed at FACScalibur using the CellQuest software (BD Bioscience; Heidelberg, 
Germany). 
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• Cells in culture or naïve lymphocytes are collected  and diluted to 105cells/well 
• 100µl of cell suspension are plated in a 96 well-plate U-shaped bottom 
• Cells are centrifuged  (4°C, 1400rpm, 4min) and working on ice the first antibody is incubated 
• After 30min, cells are washed and centrifuged twice  
• The second antibody (PE-conjugated goat ant-rat IgG) is incubated (30minutes) 
• Cells are washed and centrifuged twice 
• 10% normal rat serum (10µl/well, 10min) is incubated 
• Thy1.2-FITC coupled antibody is incubated 30min 
• Cells are washed and centrifuged and resuspended in 1%PFA/PBS 
• Cell surface molecules expression is analysed with FACScalibur and CellQuest software 
 
Table II.7.2. Flow cytometry  
 
 
 
Immunohistochemistry 
As described in Animal perfusion and tissue freezing, 6µm CNS sections were 
prepared and fixed. Samples were delimited using a PAP pen (DAKO; Hamburg, 
Germany) to avoid cross contaminations between different tissues and antibodies. 
After re-hydration of the slides in a wet close dark chamber with PBS for 5min, 
unspecific bindings were blocked treating samples for 15min with a solution of 90% 
(v/v) goat serum (Serotec) and 10% (v/v) rabbit serum (Serotec). Blocking solution 
was then removed and the primary antibody (100µl) , supernatant or purified at the 
concentration of 10µg/ml, was incubated 30min. Slides were washed 1min with PBS 
and 5min with PBS/0.1% TWEEN-20 (v/v) (Merck). The secondary biotinylated 
goat anti-rat antibody was incubated 30min and latterly sections were washed as 
described above. Afterwards, tissues were incubated with streptavidin-horseradish 
peroxidase SA/HRP (VectorStain Kit, Vector; Wertheim, Germany) 30min and, 
after another washing step, AEC kit, consisting of 3-amino-ethyl-carbazol (Vector, 
Wertheim, Germany), was incubated for 7-10min before slides were stained 1min in 
Hematoxyline (Merck). At this time slides were washed several times in normal 
water to remove excess of dyes and later on mounted with Aquatec (Merck). Using 
bright field microscope (Nikon; Egg, Switzerland), sections pictures were acquired 
using a digital camera (Nikon; Egg, Switzerland) and an ACT1 software (Nikon; 
Egg, Switzerland). 
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• 6µm sections are cut at microtome, mounted on silanized slides and fixed in acetone 
• Samples are delimited with PAP pen and re-hydrated in PBS 
• Unspecific bindings are prevented incubating slides with goat and rabbit serum 15min 
• 30min incubation with primary antibody 
• Washing step: PBS and PBS/TWEEN 20 
• SA/HRP incubation (30min) 
• Washing step: PBS and PBS/TWEEN 20 
• AEC kit incubation (7-10min) 
• 1min staining in Hematoxyline 
• Washing steps in normal water 
• Mounting with Aquatec and analysis at microscope 
 
Table II.7.3. Immunohistochemistry  
 
 
 
 
Preparation of silanized slides 
Glass slides (Vogel) were silanized to prevent tissue’s detachment. They were 
washed in acetone 5min and coated with 2% (v/v) 3-aminopropyltri-methoxysilane 
(MESPA) in acetone at RT for 5min. Afterwards slides were washed three times 
5min in acetone and air dried 1h before they were used or stored.  
 
• Slides are washed in acetone at RT 5min 
• Slides are coated in 2% (v/v) TESPA solution in acetone for 5min 
• Slides are washed three times in acetone and then dried 1h 
 
Table II.7.4. Preparation of silanized slides 
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II.8. Polymerase chain reaction 
 
Here are reported the protocols which were used to extract DNA from mouse tail 
biopsies and to analyse it by polymerase chain reaction (PCR) to identify the 
genotype of mice of interest. 
 
DNA extraction from mouse tail biopsies 
Tail biopsies of 15-21 day old mice were cut using sterile scissors. Biopsies were 
then singularly placed in 1.5ml reaction tubes (Eppendorf) and lysed overnight at 
55°C in 150µl lysis buffer (50mM  KCl, 1.5mM MgCl2, 10mM Tris-HCl pH 8.3, 
0.45% NP-40, 0.45% Tween 20) and 20mg/ml proteinase K (Merck). The lysates 
were then heat-inactivated at 95°C for 20min and the samples were stored at -20°C 
or directly used for PCR analysis. 
 
• Tails of 15-21 day old mice are cut using sterile scissors 
• Biopsies are lysed overnight at 55°C in appropriate buffer 
• Lysates are heat-inactivated at 95°C for 20min 
• Samples are stored at -20°C  or directly used for PCR analysis 
 
Table II.8.1. DNA extraction from mouse tail biopsies 
 
 
 
L-selectin neo PCR 
Two PCR reactions were done to analyse DNA of SJL/L-selectin-deficient mice. 
The first reaction was to identify the wild type L-selectin allele and required the 
primers FW1 (5’-TGC CTG GTC CTA GAA CAC TC -3’) and Rev1 (5’-GTG GTC 
CCA CAT CAG CGT AG -3’) to generate a band of 480bps. The second reaction 
was to detect the phosphoglycerate kinase promoter / neomycin resistance gene 
(PGKneo) on exon 3. This promoter was inserted into the lectin domain of the 
targeting vector containing exons 2-6 of the L-selectin genomic DNA. This vector 
was created at the University of Dallas (USA) in the group of Prof.Dr. Siegelman to 
disrupt the L-selectin locus and generate L-selectin-deficient mice (Catalina et al., 
1996). To detect PGKneo were used the primers FW2 (5’ -TGT GCC TGG TCC 
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TAG AAC ACT C -3’) and PGK-Rev2 (5’ -TGT CAC GTC CTG CAC GAC GC -
3’), generating a band of 596bps detectable on 1% agarose gel. As internal controls 
the primers Tie1-FW3 (5’ -CGA AGG GAT GGG AGA GAG AGC -3’) and Tie1-
Rev2 (5’ -TGA CGC TAT GAC GAC GAC GAT G -3’ were used as internal 
controls).  
The analysis of DNA of L-selectin mice was done mixing 1µl DNA and 19µl of 
PCR master mix composed by 
 
wild type allele     PGKneo allele 
2µl 10x PCR Buffer    2µl  10x PCR Buffer 
1.2µl 25mM MgCl2     1.2µ  25mM MgCl2
0.8µl 5mM dNTPs     0.8µl  5mM dNTPs 
14.28µl ddH2O      14.54µl  ddH2O 
0.13µl  FW1 primer     0.13µl   FW2 primer  
0.13µl  Rev1 primer     0.13µLl Rev2 primer 
0.13µl  Tie1-FW3 primer 
0.13µl  Tie1-Rev2 primer 
 
 
The reaction was performed in a PCR reaction machine (Eppendorf; Hamburg, 
Germany) and were used the following conditions: 
 
   Initial denaturation  90°C 4min 
   Denaturation   94°C 45sec 
   Hybridization   60°C 45sec  35 cycles 
   Elongation   72°C 1min 
   Final elongation  72°C 10min 
     4°C ∞ 
 
 
PCR reaction results were thus separated by agarose gel-electrophoresis. 1% agarose 
(Invitrogen) was dissolved in 0.5% TBE buffer (45mM Tris, 45mM boric acid, 
1mM EDTA) and 0.5µg/ml ethidium bromide, and solidified at RT. Gel was placed 
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in a chamber containing 0.5% TBE buffer and probes, labelled with 6x loading 
buffer, were loaded on the gel and run 30-45min at 10V per centimetre gel length. 
On the gel was also loaded a size marker (1kb marker). Probes were visualized 
exciting ethidium bromide with UV light (λ= 312nm) and picture were printed on 
thermo-paper. 
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III. RESULTS 
 
III.1 Establishment of SJL-L-selectin-deficient mice 
The L-selectin-deficient mice, provided by Mark Siegelman (University of Texas 
Southwestern Medical Centre in Dallas, Texas, USA), were backcrossed into the EAE 
susceptible SJL background to generate heterozygous mice (F1), which were then again 
backcrossed with SJL wild type mice for seven generations (F7). Heterozygous mice at 
generation F7 were bred together to generate SJL/L-selectin-deficient mice (F8) (Figure 
III.1.1). All mice used and presented in this study were females between generation F8 
and generation F18, and aged 8-10 weeks. 
  
 
X X
 
 
Figure III.1.1. Generation of SJL/L-selectin-deficient mice. Backcrossing the L-selectin-deficient strain 
into the SJL background resulted in the generation of  SJL/L-selectin heterozygous mice (generation F1-
F7). Heterozygous F7 mice were bred together to generate SJL/L-selectin-deficient mice F8.   
 
The genotype of the mice was assessed, as described in Material and Methods, by 
polymerase chain reaction. Tail biopsies were lysed and samples were analyzed by a 
double PCR to identify the wild type and the PGK neo allele. PCR results were separated 
by electrophoresis and then visualized in UV light. The genotype of mice tested was 
determined as follows: 
 
Wild type band PGK neo band Genotype 
absent present -/- 
present absent +/+ 
present present +/- 
SJL/L-selectint mouse +/-
F1 
L-selectin-deficient
-/- 
SJL wild type 
+/+ 
SJL/L-selectint-deficient mouse  
F8 
SJL/L-selectin +/-SJL/L-selectin +/-
 
 39
                                                                                                                                                      Results 
Once SJL/L-sel-/- mice were established, their phenotype was analyzed and compared to 
SJL wild type. In particular, a comparison was made of the lymphocyte populations into 
lymph nodes, spleen and blood and differences are summarized in Table III.1.1. Females 
of SJL wild type and SJL/L-sel-/- mice, of the same age, were sacrificed by cervical 
dislocation. After that, organs were dissected, homogenized and cells per organ counted. 
Blood lymphocytes, were isolated by density gradient and then counted. No differences 
in the number of lymphocytes in blood and mesenteric lymph nodes (MLN) were 
detectable between SJL wild type and SJL/L-sel-/- mice. SJL/L-sel-/- mice showed a 
dramatic reduction in the number of lymphocytes present in peripheral lymph nodes and 
showed splenomegaly compared to SJL wt mice. This experiment was repeated five 
times and data were reproducible. We can conclude that the phenotype of SJL/L-selectin-
deficient mice does not differ from the one reported in the literature for L-selectin-
deficient mice (Arbones et al., 1994; Catalina et al., 1996). 
 
 
Number of lymphocytes per organ 
 
SJL/L-sel-/- mice SJL wild type mice 
Blood 2.2·107/mL 2.5·107/mL 
Mesenteric LN 6.7·106 6.3·106
Popliteal LN 0.6·105 3.5·106
Axillary LN 2.5·105 6.2·106
Aortic LN 4.2·105 4.2·106
Inguinal LN 1.6·105 6.3·106
Spleen 5.1·108 2.3·108
 
Table III.1.1. SJL/L-selectin-deficient mice phenotype in comparison to SJL wild type littermates. 8-
10 week old mice were sacrificed by cervical dislocation. The spleen, PLN and MLN were isolated from 
each mouse, homogenized separately and cells were counted. Blood lymphocytes were separated by 
density gradient and then counted.  One representative experiment of five. 
 
 
By means of flow cytometry the phenotype of cells populating spleen, PLN and MLN of 
SJL wild type, SJL/L-selectin-/- and L-selectin-deficient mice was examined. Results 
were compared to investigate possible differences in surface molecule expression 
between different mouse strains and between different organs. Littermates were 
sacrificed by cervical dislocation and spleen, peripheral lymph nodes and the mesenteric 
lymph nodes were surgically dissected. After homogenization, cells were counted and 
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5·105 cells per well plated in 96 well plates. Cells were then stained for 30 minutes with 
monoclonal rat anti-mouse antibodies directed against cell surface molecules. After two 
washing steps, cells were stained with a phycoerythrin (PE)-coupled goat anti-rat 
antibody. After 30 minutes, cells were washed and stained with a fluorescein 
isothiocyanate (FITC) antibody, Thy 1.2-FITC, which specifically recognizes mature T 
cells. After fixation with 1% (w/v) paraformaldehyde (PFA) diluted in PBS, cell 
fluorescence was detected at FACS Calibur (BD, Heidelberg, Germany) and acquired 
data, here presented as plots of gated living cells, were analyzed using CellQuest 
software (BD, Heidelberg, Germany). PE-positive cells are identified by FL2 channel 
and FITC-positive cells are detected by FL1 channel. Several cell surface molecules were 
investigated: because interleukin (IL)-2 binding to its receptor induces cell proliferation, 
was investigated the IL-2 receptor (IL-2R). IL-2 receptor is composed of three chains: 
alpha-chain (CD25), beta-chain (CD122) and by the common gamma-chain (CD132). 
These chains can bind together to form receptors with different affinity for their ligand 
IL-2. CD25 is the low affinity receptor, CD122 and CD132 form the intermediate affinity 
receptor and only when all three chains bind together do they constitute the high affinity 
receptor (Figure III.1.2). To obtain more accurate information, different monoclonal 
antibodies (Pharmingen, Heidelberg, Germany) binding to different epitopes were used 
for each chain. CD25, which is expressed on mature and activated T cells and on 
regulatory T cells, was stained using the antibodies 7D4, PC61 and 3C7. CD122 is 
expressed on NK cells and T cells, and on T cells is upregulated upon stimulation. As 
recommended by the manufacturer, the signal produced by the antibodies TUGm2 and 
4G3, which recognize different epitopes on the common gamma-chain, was amplified 
using biotin and streptavidin, instead of phycoerythrin, and detected at FACS Calibur by 
the FL2 channel.  
Cells were stained for α4, α4β7, β7 and β1 integrins, which are involved in lymphocyte 
homing and transmigration across endothelia, and lymphocytes were also stained for 
PSGL-1, which is involved in the rolling of lymphocytes on HEV. Using an antibody 
directed against CD45RB, it was possible to discriminate between naïve (CD45RB high) 
and memory/effector (CD45RB low) CD4 positive T cells. CD62L (L-selectin) was used 
as a control. A representative experiment of the three is shown here. 
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Figure III.1.2. IL-2 receptor chains. There are three chains composing IL-2R: CD25 (alpha-chain), 
CD122 (beta-chain) and CD132 (gamma-chain or common chain). The chains can arrange themselves 
together to form receptors which show different affinity for their specific ligand. CD25 is the low affinity 
receptor, CD122 and CD132 form the intermediate affinity receptor and all three chains together create the 
high affinity receptor. 
 
 
As in this experiment fresh naïve primary spleens were used and these are composed of a 
mixture of cells, analysing splenocytes of SJL wild type (Figure III.1.3), SJL/L-selectin-
deficient (Figure III.1.4) and L-selectin-deficient (Figure III.1.5) mice, it is immediately 
evident that there is a population of cells which is negative for the T cell marker Thy1.2 
and a second population which is composed of mature Thy1.2 positive cells. CD25 could 
be detected on less than 1% of Thy1.2 positive cell surface in all three mouse strains 
investigated, and any significant difference was noticed between SJL wt and SJL/L-sel-/- 
and L-selectin-deficient splenocytes. With reference to CD122, in comparison to wild 
type mice, there is a slight increase in SJL/L-sel-/- and in L-selectin-deficient CD122 
positive splenic lymphocytes. CD132 detection is different, as both antibodies used gave 
different results. On the one hand, the amount of double positive cells detected using the 
monoclonal antibody TUGm2 is higher in SJL/L-selectin-deficient mice compared to 
SJL wild type and L-selectin-deficient mice. On the other hand, 31.6% of Thy1.2 
positive cells are clearly positive for IL-2R using 4G3 in SJL wt splenocytes, whereas in 
SJL/L-selectin-deficient mice CD132 positive cells are less (18.6%) and only few IL-2R 
common gamma-chain positive T cells are detectable in L-selectin-deficient mice using 
4G3 (2.1%). α4 and α4β7 integrin positive T cells are detectable in all splenocytes here 
investigated and LFA-1 expression on Thy1.2 positive cells is always high, particularly 
in SJL/L-selectin-deficient mice (53.4%). Integrin β7 positive T cells were more 
detectable in SJL wild type and in SJL/L-sel-/- than in L-selectin-deficient splenocytes, 
whilst β1 positive splenocytes are detectable only in SJL wt mice. In fact, β1 integrin 
CD122 CD122 
Low affinity Intermediate affinity High affinity 
CD25 
CD25 
CD132 CD132
IL-2 IL-2IL-2
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could hardly be detected on the cell surface of SJL/L-sel-/- (0.33%) and L-selectin-
deficient (1.6%) splenocytes. CD45RB high cells were present in all populations 
investigated and, interestingly, also a population of cells which is Thy1.2 positive and 
CD45RB low is present in SJL wt splencytes. PSGL-1 is expressed not only on T cells; 
in fact also the Thy1.2 negative cells expressed this molecule on their surface. CD62L 
was used as a control, and, as expected, L-selectin positive cells were detectable only in 
SJL wild type mice.  
The same protocol was used to stain and analyze lymphocytes populating peripheral 
lymph nodes. In this case only cells of SJL wild type (Figure III.1.6) and SJL/L-sel-/- 
(Figure III.1.7) mice were used. In fact, due to the small size of PLN in L-selectin-
deficient mice, it was not possible to isolate organs and to investigate them. From the 
plots presented here, a difference immediately arises compared to splenocytes: in PLN, 
the main population is composed of Thy1.2 positive cells. With reference to IL-2R alpha-
chain, no significant differences were noticed between the two groups analyzed. In fact, 
only few lymphocytes within the PLN express CD25 on their surface and none of the 
antibodies used could detect it. CD122 levels detected using TMβ1 and 5H4 were low in 
SJL wild type and in SJL/L-sel-/- peripheral lymph nodes lymphocytes. In the case of 
SJL/L-selectin-deficient mice, Thy1.2 positive and CD122 negative cells are subdivided 
in two subpopulations. A quarter of the Thy1.2 positive T lymphocytes, either SJL wt or 
SJL/L-sel-/-, was positive also for CD132 using the antibody TUGm2. The number of 
CD132 positive Thy1.2 positive cells was higher using the TUGm2 antibody compared 
to 4G3. α4, α4β7 and β1 integrin were clearly positive on Thy1.2 positive SJL wild type 
PLN cells and not on SJL/L-sel-/- PLN lymphocytes. On the contrary, in SJL wt and 
SJL/L-sel-/- PLN, LFA-1 was also detectable on Thy1.2 positive cells. On Thy1.2 
positive cells of SJL/L-selectin-deficient PLN, β7 integrin was detected only on 5.4% of 
the lymphocytes. The CD45RB fluorescence intensity detected in SJL wild type and 
SJL/L-sel-/- PLN was extremely high (naïve cells). The percentage of PSGL-1 positive 
cells was also high: 74% on SJL wt and 58.8% on SJL/L-sel-/-  PLN lymphocytes. As 
expected, in SJL/L-sel-/- PLN lymphocytes were not positive for CD62L, but only a small 
population of lymphocytes was Thy1.2 positive. In SJL wt mice, PLN cells were CD62L 
positive, but again only a minor portion was Thy1.2 positive.  
Mesenteric lymph nodes in L-selectin-deficient mice were tiny and it was not possible to 
isolate a sufficient quantity of cells to analyze them. Thus only data relative to SJL wild 
type (Figure III.1.8) and SJL/L-sel-/- (Figure III.1.9) mice is presented here. Littermates 
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were sacrificed and MLN dissected as described above. The staining procedure did not 
differ from the one already described for splenocytes and PLN cells. In MLN the main 
cell population is composed by Thy1.2 negative cells, as in spleen. Within the Thy1.2 
positive cells detectable in MLN, neither SJL wt nor SJL/L-selectin-deficient mice 
expressed IL-2R alpha- and beta-chain at all. CD132 is, instead, detectable on MLN 
Thy1.2 high cells, and compared to spleen and PLN, using TUGm2 or 4G3, there is a 
reduction of lymphocytes expressing IL-2R gamma-chain on their surface. By 
comparison, Thy1.2 positive mesenteric T cells display α4, α4β7, β7 integrins and LFA-1 
on their surfaces. It is important to note that β1 integrin on SJL/L-selectin-deficient 
mesenteric lymphocytes is not expressed (0.34%) and is only partially detectable on SJL 
wild type Thy1.2 positive cells (7.7%). On Thy1.2 positive cells, CD45RB was equally 
present on SJL wt (27%) and SJL/L-sel-/- (28%) mesenteric lymphocytes. There were no 
differences Thy1.2 high PSGL-1 high comparing SJL wt (35%) and SJL/L-selectin-
deficient (30%) MLN lymphocytes.  
To summarize, the IL-2R alpha-chain is not detectable with any of the monoclonal 
antibodies used in spleen, PLN and MLN of SJL wild type, SJL/L-sel-/- and L-selectin-
deficient mice. CD122 is partially detectable only on splenocytes of SJL/L-selectin and 
L-selectin-deficient littermates. In PLN and MLN levels of IL-2R beta-chain could not 
be detected. Compared to what was seen in the spleen and peripheral lymph nodes, in 
mesenteric LN there is a reduction in CD132 detection. With regard to integrins, are all 
present on SJL wild type, SJL/L-sel-/- and L-selectin-deficient splenocytes, PLN and 
MLN lymphocytes. The only exception is β1 integrin, which is only detectable on SJL wt 
Thy1.2 positive cells in spleen and PLN. All mice used for the experiment were naïve 
mice and, as expected, the CD45RB levels were high. PSGL-1 is always present on the 
cells analyzed, either Thy1.2 positive or negative. However, on SJL wt and SJL/L-
selectin-deficient splenocytes and in MLN, as well on SJL/L-selectin-deficient PLN, 
there is a cell population which is double negative for Thy1.2 and for PSGL-1. CD62L is 
only present on cells originating from SJL wild type littermates. 
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Figure III.1.3. Phenotype of SJL wild type splenocytes. SJL wild type splenocytes were stained to detect 
cell surface molecules expression. CD25, CD122 and CD132 are not detectable on cells surface. CD132, 
detected by the monoclonal antibody 4G3, is expressed at high levels on Thy1.2 positive SJL wt 
splenocytes. All integrins are detectable and CD45RB is highly expressed, as PSGL-1. CD62L is 
detectable on splenocytes. Data is represented as plots of living cells. FITC staining is detected at FACS 
Calibur by the FL1 channel, PE fluorescence is captured by FL2 channel. One experiment of three. 
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Figure III.1.4. Phenotype of SJL/L-selectin-deficient spleen. CD25 is poorly expressed on splenocytes. 
CD122 and CD132 (TUGm2) are slightly upregulated on cells surface. There is any impairment in integrin 
expression, with the exception of β1 integrin, which is not expressed. CD45RB and PSGL-1 are high. 
CD62L is not detectable on splenocytes. Data is represented as plots of living cells. FITC staining is 
detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by FL2 channel. One 
experiment of three. 
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Figure III.1.5. Phenotype of L-selectin-deficient spleen. Low expression of IL-2receptor molecules on 
cells surface. There is an impairment in β7 and β1 expression. CD45RB and PSGL-1 levels are high. 
CD62L is not detectable on splenocytes. Data is represented as plots of living cells. FITC staining is 
detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by FL2 channel. One 
experiment of three. 
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Figure III.1.6. Phenotype of SJL wild type PLN cells. CD25 and CD122 are not detectable on PLN cell 
surface. CD132 (4G3) is instead expressed on PLN lymphocytes. α4, α4β7, β1, β2 and β7 integrin levels are 
high. CD45RB, PSLG-1 and CD62L are detectable on lymphocytes. Data is represented as plots of living 
cells. FITC staining is detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by FL2 
channel. One experiment of three. 
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Figure III.1.7. Phenotype of SJL/L-selectin-deficient PLN cells. The only IL-2R molecule expressed is  
the CD132 (4G3). β2 and β7 integrin levels are comparable to SJL wt PLN cells, there is impairment in α4, 
α4β7 and β1 expression on cells surface. Thy1.2 positive CD45RB and PSGL-1 positive cells are 
detectable, CD62L is not expressed on SJL/L-sel-/- cells. Data is represented as plots of living cells. FITC 
staining is detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by FL2 channel. One 
experiment of three. 
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igure III.1.8. Phenotype of SJL wild type mesenteric lymph node cells. IL-2 receptor molecules and 
 
F
β1 integrin are not expressed on MLN cell surface. α4, α4β7, β7 and β2 integrins are expressed. CD45RB, 
PSGL-1 and CD62L positive lymphocytes are present on cells surface. Data is represented as plots of 
living cells. FITC staining is detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by 
FL2 channel. One experiment of three. 
 
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
Control CD45 Thy1.2-FITC CD25 (7D4) 
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
CD25 (PC61) CD122 (5H4) CD122 (TMβ1)CD25 (3C7) 
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
CD132 (TUGm2) CD132 (4G3) α4 integrin α4β7 integrin
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
 β7 integrin LFA-1 β1 integrin
CD45RB PSGL-1 CD62L 
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
100 101 102 103 104
FL1-H
                                                                                                                                                      Results 
 51
 
 
 
Figure III.1.9. Phenotype of SJL/L-selectin-deficient mesenteric lymph node cells. IL-2 receptor 
molecules and β1 integrin are not expressed on MLN cell surface. α4, α4β7, β7 and β2 integrins are 
expressed. CD45RB and PSGL-1 positive lymphocytes are present on cells surface. CD62L is not 
detectable on SJL/L-sel-/- MLN lymphocytes. Data is represented as plots of living cells. FITC staining is 
detected at FACS Calibur by the FL1 channel, PE fluorescence is captured by FL2 channel. One 
experiment of three. 
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To draw a conclusion, it was possible to confirm that Thy1.2 positive cells are lacking 
CD25 and CD122 on splenocytes, PLN and MLN derived cells in SJL wt, SJL/L-sel-/- 
and L-selectin-deficient mice. Instead, CD132 was detectable using TUGm2 and 4G3 
antibody. Intermediate values of α4 integrin were detectable on SJL wild type and SJL/L-
sel-/-splenocytes, PLN and MLN lymphocytes. In the experiment described here, we 
detected integrins on lymphocyte surface, with the exception of β1 which is only present 
on SJL wt splenocytes and PLN cells. In contrast, in the other two tests performed, we 
identified only LFA-1 on cell surface of SJL wild type and SJL/L-selectin-deficient 
lymphocytes. Data relative to CD45RB and PSGL-1, which were high in all cell types 
investigated, were reproducible. As expected, CD62L was detectable only on the surface 
of cells coming from SJL wild type mice. 
 
 
 
 
III.2. active experimental autoimmune encephalomyelitis (aEAE) 
After the generation of SJL/L-selectin-deficient mice, the goal was to investigate if L-
selectin plays a role in vivo in the recruitment of encephalitogenic T cells across the BBB 
and in the immunopathogenesis of EAE. As described in Material and Methods, aEAE 
was induced in SJL wild type and SJL/L-sel-/- by active immunization with an emulsion 
of CFA and PLP peptide, amino acids 139-151 (PLP139-151). On day 1 and day 3 post 
immunization (p.i.) an intravenous injection of heat-inactivated Bordetella pertussis 
micro-organisms was given to SJL wild type and SJL/L-selectin-deficient mice. Clinical 
symptoms and weight change were scored daily. Figure III.2.1 shows one experiment of 
four in which aEAE was induced and compared in SJL wild type and SJL/L-sel-/- mice. 
The experiment presented here was performed with four mice per group. Comparison of 
the day of disease onset did not show any significant difference between SJL wild type 
(10.3±1.50) and SJL/L-sel-/- (11±1.0). In addition, both groups analyzed suffered a 
comparable severity of disease. In fact, mice developed parallel disease and after a peak 
of severity of disease on day 12 post immunization, which was slightly more severe in 
SJL wt mice, animals exhibited a mild disease for about two weeks before they fully 
recovered. Furthermore, the SJL/L-sel-/- mice seemed to recover more gradually between 
day 22 and day 28 p.i. compared to the SJL wt mice. The weight change graph presented 
in Figure III.2.1 illustrates a parallel reduction in body weight in SJL wild type and 
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SJL/L-sel-/- mice until day 12 post immunization, which corresponds to the peak of 
severity of disease. This reduction in body weight is followed by a continuing 
reconstitution of the original weight detected prior to immunization. The SJL/L-sel-/- 
mice, even if completely recovered and not exhibiting any longer detectable clinical 
symptoms, were not able to fully reconstitute their original body weight within the 
observation period (33 days). 
 
 
Figure III.2.1. active experimental autoimmune encephalomyelitis (aEAE) comparison in SJL wild 
type and SJL/L-sel-/- mice.  aEAE was induced in 8-10 week old females of SJL wt (blue) and SJL/L-sel-/- 
(red) mice. Mice develop parallel disease and no significant differences were noticed on the day of onset of 
disease and severity of disease between the two groups. Within the observation period (33 days) SJL wt 
mice were able to fully recover their original body weight whereas the SJL/L-sel-/- group did not. Clinical 
score and weight change are expressed as mean value ± SD. One experiment of four. 
 
 
 
At the end of the observation time (33 days p.i.), animals were sacrificed and perfused 
with a 1% solution (w/v) paraformaldehyde (PFA) in PBS. Surgically the CNS was 
dissected, cut in pieces and snap frozen in cryomolds, as described in Material and 
Methods. Frozen brain and spinal cord were cut at microtome (6µm tissue sections) and 
stained to detect CD45-positive cell infiltrates in SJL wt and SJL/L-selectin-deficient 
mice. Tissue sections were fixed in acetone at -20°C and air dried for 1 hour. After re-
hydration with PBS and washing with a solution of PBS and Tween-20, samples were 
stained with the first antibody, which in our case were anti-CD45 and anti-PECAM-1: 
anti-CD45 was used to detect cells infiltrating into the CNS; anti-PECAM-1 was used as 
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positive control to detect blood vessels. Then sections were stained with the secondary 
biotinylated antibody which was followed by a streptavidin-horseradish peroxidase and 
visualized by a hematoxyline counterstaining. At the end of the staining procedure, slides 
were observed under a microscope. In Figure III.2.2 is shown an example of 
immunohistochemical analysis of CNS (cerebellum) of EAE affected mice, which were 
sacrificed on day 33 post injection. CD45 positive cell infiltrates were detected  both in 
SJL wild type and SJL/L-selectin-deficient mice, brain and spinal cord. CD45 positive 
cells accumulate into the perivascular spaces, as demonstrated by the colocalization with 
PECAM-1 positive staining, and form inflammatory cuffs.  
 
 
 
Figure III.2.2. Inflammatory CD45 positive cell infiltrates.  CD45 positive cells in SJL wild type and 
SJL/L-selectin-deficient cerebellum. CD45 positive cells form inflammatory cuffs as shown by 
colocalization with PECAM-1, which is a marker for blood vessels. Mice were sacrificed on day 33 post 
immunization. CD45 positive cells were stained using the monoclonal antibody M1/9; PECAM-1 positive 
cells were stained using the monoclonal antibody Mec13.3. Hematoxyline counterstaining. 
 
 
This experiment was repeated 3 times using animal of the same age (8-10 weeks old) and 
from different backcrossing generations (Table III.2.1). Only during the first test, in SJL 
wild type and in SJL/L-selectin-deficient mice disease was delayed compared to the other 
experiments, and in this particular experiment both mouse groups developed mild 
disease. However, during the last three aEAE tests there were no significant differences 
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concerning the day of the onset of disease and the severity of disease scored in SJL wt 
and SJL/L-sel-/- mice. 
 
Day of onset of disease Severity of disease 
Experiment 
number 
Number of mice 
per group 
SJL wt 
mice 
SJL/L-sel-/- 
mice 
SJL wt 
mice 
SJL/L-sel-/- 
mice 
1 8 19.50±6.39 23.71±4.23 0.88±0.88 0.71±0.27 
2 6 12.83±1.83 14.67±2.73 1.25±1.37 1.50±0.55 
3 4 13.25±1.50 16.57±2.64 1.87±1.30 1.20±0.90 
4 4 10.30±1.50 11.0±1.0 1.33±0.57 0.75±0.40 
 
 
Table III.2.1. aEAE comparison in SJL wild type and SJL/L-sel-/- mice. Comparison of the day of onset 
of disease and severity of disease in four different experiments in SJL wild type and SJL/L-sel-/- mice. In 
one case mice developed a delayed and less severe disease in comparison to the next experiments. 
Regarding the last three aEAE test performed, both mouse groups had a similar severity of disease and day 
of onset of disease. Data are expressed as mean value ± SD. 
 
 
 
 
III.3. Passive transfer of experimental autoimmune encephalomyelitis 
(tEAE) with SJL wild type PLP-specific T cell blasts 
From aEAE studies it was evident that L-selectin does not play a role in the recruitment 
of encephalitogenic across the BBB and in the immunopathogenesis of EAE. Previous 
investigations demonstrated that, when encephalitogenic T cells are activated in vitro and 
are injected in mice to transfer EAE, inflammatory cells do not enter the lymph nodes to 
be activated, but rather, encephalitogenic T cells directly circulate in the blood, reach the 
BBB and induce inflammation (Wekerle et al., 1986; Hickey and Kimura, 1988).Thus, 
the next goal was to investigate if in vitro activated SJL wild type PLP-specific T cell 
blasts can transfer EAE also in SJL/L-sel-/- mice. Disease was passively transferred 
(tEAE) by intravenous injection of established PLP-specific SJL wild type T cell lines. 
The T cell line SJL.PLP4, which was previously established and characterized, was 
restimulated, as described in Material and Methods, in the presence of the specific 
antigen PLP139-151 at the concentration of 10µg/mL. The proliferation efficiency and the 
specificity for the specific antigen PLP139-151 was assessed, by a 3H-Thymidine 
incorporation assay, for each T cell line used for tEAE induction. Cells were co-cultured 
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in 96 well plates, in triplicates, with sublethally irradiated splenocytes in the presence of 
their specific antigen PLP139-151, in the presence of the mitogen Concanavalin A (ConA) 
and of the unspecific antigen Mycobacterium tuberculosis purified protein derivate 
(PPD). As a control, cells were also plated in the absence of antigens to obtain data 
relative to baseline proliferation. After three days, cells were labelled with 3H-Thymidine 
which was incorporated into the DNA. After 16h, cells were harvested and 3H-dT 
incorporation was measured by a beta-counter as counts per million (cpm). Elevated cpm 
have been detected in those samples which had high proliferation. As shown in Figure 
III.3.1, SJL.PLP4 T cells have a high response and an extremely significant specificity 
for the PLP139-151 antigen. ConA was the positive control in this assay and cells 
moderately proliferated in its presence. Baseline levels are measured in the absence of 
antigens and in the presence of PPD. The same results were obtained with the T cell lines 
SJL.PLP36, SJL.PLP37 and SJL.PLP42. 
 
Figure III.3.1. Antigen specificity of the SJL.PLP4 T cell blasts. T cells were co-cultivated with 
sublethally irradiated splenocytes and labelled with 3H-dT after three days. In the presence of their specific 
antigen PLP139-151 the SJL.PLP4 T cells have an high proliferation. In response to the mitogen ConA, our 
internal positive control, cells moderately respond. In the presence of the non specific antigen 
Mycobacterium tuberculosis protein purified derivate (PPD) cells do not proliferate as in the absence of 
antigens in culture (baseline proliferation). Data is represented as mean value of the 3H-dT incorporation 
(cpm) detected at beta-counter ± SD. 
 
 
After three days in culture with sublethally irradiated splenocytes, which function as 
antigen presenting cells, T cell blasts were isolated by density gradient. SJL.PLP4 T cell 
blasts were diluted in PBS and 3·106 cells per mouse were injected intravenously in SJL 
wild type and SJL/L-selectin-deficient mice (n=3). Daily clinical symptoms and weight 
change were scored and are reported here as mean values ± standard deviation, in Figure 
III.3.2. The day of the onset of disease in SJL wild type (8.33±0.58) was comparable to 
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the disease onset in SJL/L-sel-/- mice (8.67±1.15). The disease curves for both mouse 
groups proceeded in parallel and reached the peak of severity on day 10-17 post injection 
(p.i.). SJL wild type mice (blue curve) developed a non-significant slightly less severe 
disease compared to the SJL/L-sel-/- mice (red curve) and had a second peak of disease 
around day 18 p.i. Within the observation period (30 days) mice were not able to recover 
and were sacrificed when they still had severe disease. Observing the weight change 
graph, after injection of SJL.PLP4 blasts, mice increased their body weight and then, as 
clinical symptoms started to be detectable, they gradually lost body weight and reached a 
peak corresponding to the peak of severity of disease. Interestingly, SJL wt mice lost 
more weight compared to SJL/L-selectin-deficient mice. At around day 13 p.i. both 
mouse groups regularly started to regain body weight, but SJL wt and SJL/L-sel-/- 
littermates did not fully recover within the observation period. To conclude, injections of 
SJL wild type PLP-specific SJL.PLP4 T cell blasts in SJL wild type and SJL/L-selectin-
deficient recipients induced the development of clinically detectable EAE and induced a 
loss of body weight. In addition, it is important to mention that, even if SJL wild type 
mice lost more body weight than SJL/L-selectin-deficient recipients on day 9-12 p.i., this 
did not correlate with an increased severity of disease. In fact, in the experiment shown 
here, the SJL/L-sel-/- mice were to develop a slightly more severe tEAE compared to SJL 
wt mice. 
 
 
Figure III.3.2. Adoptive transfer of experimental autoimmune encephalomyelitis (tEAE) comparison 
in SJL wild type and SJL/L-sel-/- littermates. 3·106 SJL.PLP4 T cell blasts per mouse were intravenously 
injected in SJL wt (blue) and SJL/L-sel-/- mice (red). Mice developed parallel disease and there was a 
significant difference in the severity of disease. In correspondence to the development of disease, mice lose 
body weight and are not able to completely recover it within the observation period (30 days p.i.). Data are 
presented as mean values of clinical score and weight change ± SD. One experiment of four. 
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tEAE was induced in SJL wt and SJL/L-sel-/- mice four times using different SJL wt PLP-
specific T cells lines (Table III.3.1). All T cell lines used were restimulated five times 
before being injected in mice to transfer EAE. SJL wild type and SJL/L-selectin-deficient 
mice develop disease around day 8-13 p.i. and there are not significant differences in 
regard to the day of onset of disease. Concerning the severity of disease, in the case of 
SJL.PLP4 blasts injection SJL/L-sel-/- mice developed a higher severity of disease 
compared to the other tests performed. In SJL wild type mice, with the exception of 
disease induced by SJL.PLP42 blasts, which was comparable with the score detected in 
SJL/L-sel-/- recipients, SJL wild type mice developed a higher severity of disease than 
their counterparts. 
 
Day of onset of disease Severity of disease SJL wt PLP-
specific T cell lines 
injected 
SJL wt mice SJL/L-sel-/- mice SJL wt mice SJL/L-sel-/- mice 
SJL.PLP4 8.33±0.58 8.67±1.15 2.33±0.58 2.33±1.15 
SJL.PLP36 9.50±0.70 10.0±0.0 1.60±1.50 0.83±0.28 
SJL.PLP37 8.50±2.12 13.3±4.94 2.503±0.70 0.75±0.35 
SJL.PLP42 9.50±0.70 11.5±0.70 0.50±0. 0 0.75±0.35 
 
Table III.3.1. tEAE comparison in SJL wild type and SJL/L-sel-/- mice. Comparison of the day of onset 
of disease and severity of disease in four different experiments in SJL wild type (blue) and SJL/L-sel-/- 
mice (red) injected with 3·106 SJL wt PLP-specific blasts per mouse. No significant differences are 
emerging from the analysis of the day of onset of disease between the two groups analyzed and between 
different experiments.  The severity of disease is apparently higher in SJL wt mice, with the exception of 
the test performed with SJL.PLP4 and SJL.PLP42 T cell blasts. Data are expressed as mean value ± SD. 
 
 
 
The phenotype of PLP-specific SJL wild type T cells was investigated by flow cytometry 
as already published (Laschinger et al., 2000). The freshly isolated T cell blasts of the T 
cell line SJL.PLP38 (Figure III.3.3) were collected and 105 cells per well plated in a 96 
well plate and stained with monoclonal antibody. The monoclonal antibodies used were 
directed against the IL-2 receptor (see Figure III.1.3), to investigate if there was an 
impairment in cell proliferation. Antibodies directed against cell surface molecules 
involved in lymphocyte homing and transmigration were also used, such as α4, α4β7, β1 
and β7 integrin, and PSGL-1, which is involved in the rolling of lymphocytes on HEV. 
CD45RB was investigated to distinguish naïve (CD45RB high) and effector/memory T 
cells (CD45RB low). As positive control CD45 was detected and CD8 as negative 
control. After 30 minutes, cells were washed and stained with the secondary antibody 
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PE-coupled. After fixation with 1% (w/v) paraformaldehyde in PBS, cell fluorescence 
was detected at FACS Calibur (BD, Heidelberg, Germany) and data were analyzed with 
the CellQuest software (BD, Heidelberg, Germany). Data are here presented as 
histograms of gated living PE labelled cells (FL2 channel). Freshly isolated T cell blasts 
are CD45 positive and CD8 negative. The fluorescence intensity detected for LFA-1 and 
for PSGL-1 was high. Compared to the positive and the negative control, the SJL.PLP38 
T cell blasts here analyzed present intermediate levels for CD3, integrins α4, α4β7, and 
β7, and for CD45RB. β1 integrin was only slightly positive, compared to the isotype 
control. 
 
 
Control CD45 CD8 CD3 
 
 
Figure III.3.3. Phenotype of PLP-specific SJL wild type SJL.PLP38 T cell blasts.  By flow cytometry 
was investigated the phenotype of freshly isolated PLP-specific SJL.PLP38 blasts. Blasts are positive for 
CD45 and PSGL-1, negative for CD8 and only slightly positive for integrins and CD45RB. The isotype 
control is represented in black. Data is shown as histograms of gated living PE labelled cells and detected 
at FACS Calibur in FL2 channel. 
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III.4. Passive transfer of experimental autoimmune encephalomyelitis 
(tEAE) with SJL/L-selectin-deficient PLP-specific T cells 
After the generation of SJL/L-selectin-deficient mice and the induction of aEAE and the 
transfer of disease with SJL wt T cells blasts, the goal was to transfer EAE using in vitro 
activated PLP-specific SJL/L-sel-/- T cell blasts. For this reason, PLP-specific SJL/L-sel-/- 
T cell lines were generated. As described in Material and Methods, mice were 
immunized with an emulsion of CFA and PLP139-151. After 10-14 days post 
immunization, mice were sacrificed by cervical dislocation and spleens were surgically 
isolated. Organs were homogenized and cells plated in the presence of PLP139-151 at the 
concentration of 10µg/mL. After four days in culture, cells were isolated by density 
gradient and plated in Petri dishes containing TCGF medium. Under the microscope, 
cells looked like their counterparts SJL wild type, but it was not possible to maintain 
them in culture because they all died within 36 hours in the culture. The hypothesis was 
about an impairment in IL-2 synthesis and IL-2R expression on cell surface. Therefore, 
freshly isolated SJL/L-selectin-deficient T cells were cultivated in the presence of mouse 
recombinant (mr) IL-2 and/or IL-15 and compared to cells cultivated in normal TCGF 
medium. Cells were kept in the culture and, even with difficulties, cells cultivated with 
mr IL-2 and mr IL-15 were able to survive longer than cells cultivated only with TCGF 
medium, but did not proliferate. After two days in culture, cells were analyzed by flow 
cytometry for CD25 and CD122 expression (Figure III.4.1). CD25 was detected by the 
monoclonal antibody anti-mouse 7D4, PC61 and 3C7; CD122 expression was 
investigated by the anti-mouse monoclonal antibody TMβ1 and 5H4. IL-2R alpha-chain 
detection with the antibody 7D4 and PC61 did not show any difference compared to the 
isotype control. In the presence of mouse recombinant IL-2 and IL-15, using 7D4 and 
PC61 antibodies could not be detected CD25, suggesting that mouse recombinants did 
not stimulate cells to synthetize IL-2 receptors. 3C7, which recognizes CD25 on 
activated T cells, was detectable on all the cells analyzed. In SJL/L-sel-/- PLP7 T cells 
maintained in a culture medium containing both mr IL-2 and mr IL-15, using 3C7 was 
detected a double peak: one was negative for 3C7 (naïve T cells), the second one was 
slightly positive. The presence of mr IL-2 or mr IL-15 in culture media did not increase 
the amount of CD122 positive detectable. 
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Because the addition of mr IL-2 and mr IL-15 to cell culture medium did not result in an 
increase in cell proliferation this approach was dismissed. Thus the strategy was to 
generate primary PLP-specific T cell lines and to test them in vitro and in vivo. 
 
 
 
Figure III.4.1. CD25 and CD122 expression of SJL/L-sel.PLP 7 cells cultivated with mouse 
recombinant IL-2 and IL-15. SJL/L-sel-/-.PLP7 T cells were kept in culture in the presence/absence of mr 
IL-2 and mr IL-15. CD25 is not detectable using the antibody 7D4 and PC61. 3C7, which recognize 
another epitope of CD25, is slightly positive also in cells cultivated with the normal cell culture medium 
TCGF. A small portion of CD122 positive cells is present in all cultures. The cells grown in TCGF 
medium are shown in blue; the cells cultivated in presence of mr IL-15 are shown in red ; the cells grown 
in presence of mr IL-2 are shown in orange and the cells cultivated with both mr IL-2 and mr IL-15 are 
represented in green. The isotype control is shown in black. 
 
 
 
 
III.5. Comparison of tEAE induced with primary T cells 
In vitro activated primary PLP-specific T cells lines were generated as described in 
Material and Methods. Briefly, 10-14 days post immunization with CFA and PLP139-151, 
mice were sacrificed and spleen were isolated, homogenized and splenocytes plated four 
days in presence of PLPP139-151 antigen. After isolation by density gradient, newly 
generated blasts were cultivated in cell culture. Ten PLP-specific SJL/L-sel-/- primary T 
cell lines were created in Germany and seven more were generated in Switzerland. All 
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primary cell lines generated in the laboratory in Münster failed to be maintained in the 
culture. The seven primary SJL/L-selectin-deficient T cell lines generated in Switzerland 
could be cultivated in normal TCGF medium. For reasons still unclear, freshly isolated 
PLP-specific blasts generated in Switzerland could be kept in culture and replicated, but 
lower than SJL wild type PLP-specific primary T cell blasts. Thus, the phenotype of the 
primary SJL/L-sel.PLP17 T cells was investigated and compared to the primary 
SJL.PLP49 T cells. Blasts on day 0 and cells on day 1 and day 3 post gradient were 
stained to detect CD25, CD122 and CD132, which together form the receptor for IL-2, a 
cytokine which stimulates cell proliferation. α , β  and β  integrins were also detected, 
which are involved in lymphocytes homing and diapedesis, and CD45RB to discriminate 
between naïve (CD45RB high) and effector/memory cells (CD45RB low). PSGL-1, 
which is involved in lymphocyte rolling on HEV, was investigated using the monoclonal 
antibody 4RA10. Cells were stained for CD45 as a positive control. The protocol for 
staining has already been described above. At FACS Calibur (BD, Heidelberg, Germany) 
the fluorescence intensity of the surface molecules investigated was detected and the data 
were analyzed using CellQuest software (BD, Heidelberg, Germany). Data are here 
represented as overlay histograms of gated Thy1.2-FITC positive living cells. Only a few 
CD25 positive cells are detectable on the surface of SJL/L-sel.PLP17 T cells on day 0 
(blue line), day 1 (red line) and day 3 (black line) post gradient (Figure III.5.1). CD122 
was not detectable on primary SJL/L-sel
4 1 7
-/- PLP-specific blasts and cultivated cells. 
CD132 expression detected using the monoclonal antibody TUGm2 revealed that on day 
0 and on day 1 over half of the SJL/L-sel.PLP17 T cells present IL-2R gamma-chain on 
their surface. A slight reduction in cell counts and fluorescence intensity was observed on 
day 3 post gradient. The use of 4G3 to detect CD132 revealed that this antibody 
recognized only few Thy1.2 positive CD132 positive cells. While β  and β  integrin were 
identified only on the surface of few primary SJL/L-sel
7 1
-/- cells, α  integrin recognition 
was different at each analysis. In fact, on day 0 only few SJL/L-sel.PLP17 T blasts 
presented α  integrin and detection diminished on day 1. On day 3, instead, α  integrin 
was present again on the surface of half of the SJL/L-sel.PLP7 T cells analyzed. SJL/L-
sel.PLP17 T cells were effector/memory cells (CD45RB low) but PSGL-1 high.  
4
4 4
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Figure III.5.1. Phenotype of PLP-specific primary SJL/L-sel.PLP17 T cells on day 0, day 1 and day 3 
post isolation. Only few SJL/L-sel.PLP17 T cells expressed CD25 and CD122 on their surface. TUGm2 
was the only antibody able to recognize the expression of CD132 on SJL/L-sel.PLP17 T cells. Cells were 
negative for β7 and β1 integrins and for CD45RB, and slightly positive for α4 integrin. PSGL-1 levels on 
cell surface were high. The analysis on day 0 is represented in blue; the analysis on day 1 is shown in red 
and the analysis on day 3 post isolation per density gradient is shown in black. Data are shown as 
histograms overlays of gated Thy1.2-FITC living cells. FL2 indicates the fluorescence intensity of PE 
positive cells. 
 
 
 
In comparison, the phenotype of SJL.PLP49 T cells on day 0 and day 1 and day 3 after 
isolation was investigated (Figure III.5.2). Only few cells expressed CD25 and CD122 on 
their surface. An exception was the detection of CD122 by the antibody 5H4. In fact, on 
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day 1 some CD122 positive cells could be found. Using 4G3 antibody, only few CD132 
positive cells were measurable, but using TUGm2 on day 0 and 1, it was possible to 
identify CD132 on the surface of SJL.PLP49 T cells. α4 and β7 integrins were detectable 
on few SJL.PLP49 primary cells, whilst β1 levels were slightly positive on day 1. 
SJL.PLP49 T cells were CD45RB high and PSGL-1 high. 
 
 
 
Figure III.5.2. Phenotype of PLP-specific primary SJL.PLP49 T cells on day 0, day 1 and day 3 post 
isolation. SJL.PLP49 T cells poorly express CD25 and CD122. CD132 is only detectable using the 
antibody TUGm2. α4 and β7 integrins were not identified on SJL.PLP49 T cell surface and β1 integrin is 
slightly positive on day 1. Cells were CD45, CD45RB and PSGL-1 positive. Cells analyzed on day 0are 
represented in blue; in red on day 1 in red and on day 3 post isolation per density gradient in black. Data is 
shown as histograms overlays of gated Thy1.2-FITC living cells. FL2 indicates the fluorescence intensity 
of PE positive cells. 
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To conclude, few SJL/L-sel.PLP17 and SJL.PLP49 primary T cells present CD25 and 
CD122 on their surface. CD132 was detectable only using the monoclonal antibody 
TUGm2. α4 integrin positive cells were detectable on SJL/L-sel-/- primary T cells and on 
SJL wt primary T cells. SJL.PLP49 cells were slightly positive for α4 and β1 integrin and 
none of the primary cell lines here analyzed presented β7 integrin on cell surface. PSGL-
1 positive cells were detectable on SJL wild type and SJL/L-sel-/- primary T cells on day 
0, day 1 and day 3 post gradient. SJL.PLP49 T cells were CD45RB positive, instead 
SJL/L-sel.PLP17 T cells were effector/memory cells (CD45RB low). Following analysis 
confirmed the data here shown. 
 
Costimulatory molecules were detected on day 2 post gradient on the surface of 
SJL.PLP45 (Figure III.5.3) and SJL/L-sel.PLP7 primary T cells (Figure III.5.4). Cells in 
culture were collected and stained with the primary antibody Thy1.2 followed by a goat 
anti-rat antibody PE-coupled. Afterwards, cells were stained using hamster anti-mouse 
CD28, CD152 and CD154 antibody followed by Alexa-Fluor 488, which is detectable at 
FACS Calibur in FL1 channel. CD28 was investigated because, working with the 
complex TCR/CD3, promotes T cells proliferation, IL-2 production and cell survival. 
CD152, known also as CTLA-4, is a negative regulator of T cell activation., also called 
CD40 Ligand, is present, for a short time upon activation, on the surface of CD4 positive 
T lymphocytes and belongs to the tumor necrosis factor superfamily. Thy1.2 was used as 
a positive control and its fluorescence was detected by FL2 channel. On SJL.PLP45 
primary T cells at day 2 post gradient, CD28 was detectable on the majority of Thy1.2 
positive cells. On SJL/L-sel.PLP7 primary T cells, the amount of CD28 positive Thy1.2 
positive cells is reduced compared to SJL.PLP45 primary cells. Low levels of CD152 
were detectable on Thy1.2 positive SJL.PLP45 and SJL/L-sel.PLP7 primary T cells, 
indicating that cells were activated. Intermediate levels of CD40 Ligand were detectable 
on the surface of Thy1.2 positive SJL.PLP45 and SJL/L-sel.PLP7 T cells. In conclusion, 
SJL.PLP45 and SJL/L-sel.PLP7 primary T cells, on day 2 post gradient, expressed 
intermediate levels of CD152 and CD154. On Thy1.2 positive SJL/L-sel.PLP7 primary T 
cells were detectable intermediate levels of CD28, whilst on Thy1.2 high SJL.PLP45 T 
cells CD28 was clearly positive, suggesting probably a better proliferation and survival. 
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control Thy1.2 
 
 
Figure III.5.3. Costimulatory molecules expression on SJL wt PLP-specific T cells. Detection of 
costimulatory molecules CD28, CD152 and CD154 expression on cells surface of SJL.PLP45 primary T 
cells on day 2 post gradient. On Alexa-Fluor positive cells are detectable high levels of CD28 and 
intermediate levels of CD152 and CD154. Data are shown as plots of living gated cells. AlexaFluor 488 
positive cells are detected by FL1channel; PE positive cells are detected by FL-2 channel. 
 
 
 
 
Figure III.5.4.  Costimulatory molecules expression on SJL/L-sel.PLP7 T cells. Detection of 
costimulatory molecules CD28, CD152 and CD154 expression on cells surface of SJL/L-sel.PLP7 primary 
T cells on day 2 post gradient. On Alexa-Fluor cells are detectable intermediate levels of CD28, CD152 
and CD154. Data are shown as plots of living gated cells. AlexaFluor 488 positive cells are detected by 
FL1channel; PE positive cells are detected by FL-2 channel. 
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After the characterization of the phenotype of SJL wild type and SJL/L-selectin-deficient 
PLP-specific primary T cells, the aim was to restimulate these cells co-cultivating them 
with sublethally irradiated splenocytes in the presence of PLP139-151 antigen. First in 
Germany and then in Switzerland, cells did not proliferate properly in response to their 
specific antigen. It was then decided to titrate PLP139-151 and test if the concentration of 
10µg/mL used previously in our assay had to be adapted. The concentration of PLP139-151 
antigen was titrated using primary SJL wild type and SJ/L-sel-/- T cell lines and also 
established wild type T cells lines. In Figure III.5.5 a representative experiment of four is 
shown and it was performed using the primary SJL.PLP57 and SJL/L-sel.PLP20 T cell 
lines. T cells were cultivated in triplicates in a 96 well plate in the presence of the 
mitogen Concanavalin A (ConA), of the M. tuberculosis protein purified derivate (PPD) 
and in the presence of PLP139-151 at different concentrations. After three days a solution 
of 3H-Thymidine was added to the cell culture medium and cells were harvested after 16 
hours. 3H-dT incorporation and T cell proliferation were measured as counts per million 
(cpm) using a beta counter. Here data are shown as percentage values and ConA (orange 
bar) was assumed as positive control having 100% proliferation. Primary cell lines are 
composed by a mixture of cells specific for different antigens. For this reason, 
SJL.PLP57 primary T blasts cells have a high proliferation in the presence of PPD (pink 
bar). Using PLP139-151 at the concentration of 100µg/mL (dark blue bar) and 50µg/mL 
(purple bar) it was not possible to detect any 3H-Thymidine incorporation into the cells. 
PLP139-151 at the concentration of 20µg/mL (blue bar) and 10µg/mL (red bar) induced a 
proliferation as high as the non specific antigen PPD. 1µg/mL (yellow bar) induced a 
lower proliferation, probably because the solution did not contain enough antigen to 
properly stimulate T cell proliferation. Cells were also tested in the absence of antigens 
(green bar) to give baseline proliferation which was, surprisingly, higher than ConA. In 
SJL/L-sel.PLP20 primary T cell blasts, surprisingly, cells did not proliferate when 
stimulated by PPD. In addition, the PLP139-151 solutions (100µg/mL, 50µg/mL, 20µg/ml, 
10µg/mL and 1µg/mL) induced cells to proliferate significantly more than the baseline 
values obtained in the absence of antigens, but all values assessed at around 100% and 
were not significantly different compared to ConA stimulation. Taken together, SJL/L-
sel.PLP20 primary T cell blasts presented here, but also in other titration performed with 
other primary T cell lines, had a less efficient response in the presence of specific and 
unspecific antigens when compared to SJL wild type primary PLP-specific T cell lines. 
According to the data acquired, it was assumed that PLP139-151 at the concentration of 
 67
                                                                                                                                                      Results 
10µg/mL was satisfactory. In fact, at the concentration of 100µg/mL and 50µg/mL it was 
not detected proliferation in SJL wild type blasts and the PLP139-151 concentration of 
20µg/mL did not significantly differ compared to the cell proliferation observed with 
10µg/mL.  
 
 
 
 
 
Figure III.5.5. PLP139-151 titration in SJL wild type and SJL/L-sel-/- PLP-specific primary T cells. 
SJL.PLP57 and SJL/L-sel.PLP20 primary T cells were plated in the presence of specific and unspecific 
antigens. ConA is the positive control within the assay (3H-dT incorporation 100%). SJL.PLP57 primary T 
cells do not proliferate when stimulated with excessively concentrated solutions of PLP139-151 (100µg/mL 
and 50µg/mL). Cells optimally proliferate in the presence of 20µg/mL and 10µg/mL PLP139-151 solutions 
and at the concentration of 1µg/mL cells have an impaired proliferation. PPD is the non specific antigen 
which stimulates SJL.PLP57 T cells to proliferate and baseline levels are given by cells plated in the 
absence of antigens in culture. SJL/L-sel.PLP20 primary T cells blasts have a reduced 3H-dT incorporation 
compared to their wild type counterparts, but significantly higher than baseline values. Surprisingly SJL/L-
sel.PLP20 T cells did not proliferate in the presence of PPD. Data are shown as percentage values of 3H-dT 
incorporation calculated on the positive control ConA. 
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However, from the restimulations it was not possible to obtain a sufficient number of T 
cells to transfer EAE in mice. Thus primary PLP-specific T cell blasts were generated 
and injected into the SJL wild type and SJL/L-sel-/- recipients. Primary SJL wild type and 
SJL/L-sel-/- PLP-specific T cell blasts were prepared in parallel and cells isolated were 
cross-injected in syngenic recipients: 
  
Injected in 
SJL wild type mice 
SJL wild type PLP-specific primary blasts 
SJL/L-sel-/- mice 
SJL wild type mice SJL/L-sel-/- PLP-specific primary blasts 
SJL/L-sel-/- mice 
 
 
 
As an example, the primary SJL.PLP50 T cell blasts are shown here. After the generation 
of the primary SJL.PLP50 cells, the 3H-Thymidine incorporation and cell proliferation 
was assessed as described above. SJL.PLP50 primary T cell blasts, as shown in Figure 
III.5.6, had a high proliferation and 3H-dT incorporation in the presence of the mitogen 
Concanavalin A. ConA represents the positive control within this assay and induces T 
cells to proliferate and consequently the measured cpm are elevated. SJL.PLP50 primary 
T blasts, compared to ConA stimulus, had a significantly reduced proliferation in the 
presence of the specific antigen PLP139-151 at the concentration of 10µg/mL. As explained 
above, primary cell lines are peculiar: in fact are composed of cells specific for different 
antigens and cell lines become PLP-specific only after several restimulations performed 
in vitro only in the presence of PLP139-151 (i.e. Figure III.3.2). Thus it was unusual to 
detect less than 1000cpm and was comparable to basal proliferation in the absence of 
antigens. The data shown here were reproducible at the generation of the other SJL wild 
type PLP-specific T cell lines. 
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Figure III.5.6. 3H-Thymidine incorporation and proliferation of the primary SJL.PLP50 T cell 
blasts. SJL.PLP50 T cell blasts massively proliferate when stimulated with the mitogen factor 
Concanavalin A. PLP139-151 induces a proliferation significantly lower than ConA, but higher than the non 
specific antigen PPD and higher than the basal proliferation obtained in the absence of antigens. Data are 
presented as mean values of the 3H-dT incorporation measured as count per million (cpm) ± SD. 
 
 
Because of the specificity for their specific antigen PLP139-151, SJL.PLP50 primary T cell 
blasts were used to transfer EAE in SJL wild type and SJL/L-selectin-deficient mice 
(Figure III.5.7). After isolation by density gradient, 2·107 SJL.PLP50 blasts per mouse 
were intravenously injected into mice. As described in Material and Methods, clinical 
symptoms and weight change were daily scored. SJL/L-sel-/- mice developed EAE earlier 
(day 10.33±0.51) than their counterparts SJL wild type mice (day 14.33±0.57). In 
addition, SJL/L-selectin-deficient mice suffered a significantly more severe disease (2±1) 
than SJL wt mice (0.58±0.14). SJL/L-sel-/- mice suffered a long disease and they did not 
recover within the observation period of 23 days. In comparison, SJL wild type 
littermates not only developed a less severe and delayed disease, but their disease curve 
was shorter than SJL/L-sel-/- mice and they recovered within 21 days. From the weight 
change graph it can be observed that the curves relative to SJL wild type and SJL/L-
selectin-deficient mice develop parallel. As shown in the weight loss graph, after 
injection mice gain weight and interestingly SJL wt mice start to loose body weight 
earlier than SJL/L-sel-/- littermates. Furthermore, SJL wild type mice weight change 
reached the peak on day 15 and was immediately followed by a gradual, but incomplete 
reconstitution of the body weight as score at the beginning of the experiment. SJL/L-sel-/- 
mice, instead, have lost more weight than SJL wt mice and reach their peak on day 17. 
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Their reconstitution of the body weight seems to be faster than that of their counterparts, 
but did not reach the original weight within the 23 days of observation. 
 
 
 
Figure III.5.7. SJL.PLP50 primary T cell blasts induce tEAE in SJL wild type and SJL/L-sel-/- mice. 
SJL.PLP50 T cell blasts induce more severe tEAE in SJL/L-sel-/- mice than in SJL wt littermates, which 
rapidly recover completely. After injection, both mouse groups slightly gain body weight, but together with 
the appearance of the clinical symptoms, mice loose weight and are not able to reach their original body 
weight within the observation time. Data are presented as mean values of the day of onset of disease and 
weight change ± SD. One experiment of four. 
 
 
A summary of the tEAE induce by SJL wild type PLP-specific T cell blasts is shown in 
Table III.5.1. Only transfer of SJL.PLP50 and SJL.PLP57 PLP-specific primary T blasts 
induced EAE in SJL wild type and SJL/L-selectin-deficient mice. The day of the onset of 
the disease, in SJL wt mice, was delayed upon injection of SJL.PLP57 primary blasts 
compared to the disease onset detected upon injection of SJL.PLP50 blasts. Only 
SJL.PLP50 blasts induced tEAE in SJL/L-selectin-deficient mice. SJL wild type mice 
developed mild disease when injected with SJL.PLP50 and SJL.PLP57 primary T cell 
blasts. SJL.PLP50 blasts transferred a severe disease in SJL/L-sel-/- mice.  
In conclusion, transfer of EAE upon injection of primary SJL wild type PLP-specific T 
cell blasts produced contradictory results. On the one side, only two out of four different 
primary cell lines induced disease in SJL wild type and in SJL/L-selectin-deficient mice. 
On the other side, only in one experiment (SJL.PLP50 primary T cells) SJL/L-sel-/- mice 
developed a significantly higher severity of disease compared to the SJL wild type 
littermates.  
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Day of onset of disease Severity of disease Primary PLP-
specific SJL 
wild type T 
cell blasts 
injected 
Number of 
mice per 
group 
SJL wt mice SJL/L-sel-/- 
mice 
SJL wt mice SJL/L-sel-/- 
mice 
SJL.PLP50 3 14.33±0.57 10.33±0.51 * 0.58±0.14 2.0±1.0 * 
SJL.PLP52 3 No disease No disease 
SJL.PLP57 4 18.0±1.73 No disease * 0.40±0.40 No disease * 
SJL.PLP58 4 No disease No disease 
 
Table III.5.1. tEAE comparison in SJL wild type and SJL/L-sel-/- mice induced by SJL wild type 
PLP-specific primary T cell blasts. Mice developed disease only upon transfer of SJL.PLP50 and 
SJL.PLP57 primary T cell blasts. Disease was more severe and developed earlier in mice injected with 
SJL.PLP50 blasts. Data are presented as mean values of the day of onset of disease and severity of disease 
± SD. * indicates significant difference. 
 
 
 
 
 
 
 
 
 
Five SJL/L-selectin PLP-specific primary T cell lines were prepared to be injected in SJL 
wild type and SJL/L-sel-/- mice. Two experiments in relation to SJL/L-sel.PLP20 primary 
T blasts are presented here. In Figure III.5.8 a graph is shown representing the specificity 
and the proliferation of SJL/L-sel.PLP20 primary blasts. In the presence of their specific 
antigen PLPP139-151. T cell blasts have a high proliferation in response to the positive 
control, the mitogen ConA. SJL/L-sel.PLP20 primary T cells have an elevated baseline 
proliferation as was measured at beta counter for cells plated in the absence of antigens. 
Higher, but not significantly different, is the proliferation upon stimulation with the 
specific antigen PLP139-151 at the concentration of 10µg/mL. The counts measured in the 
presence of PPD, the non specific antigen, were relatively high, as was also seen during 
the titration experiments for PLP139-151 antigen. This experiment was reproduced for each 
newly generated primary T cell line and discrepant data about ConA were only obtained 
in two cases, which did not induce high proliferation 
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Figure III.5.8. 3H-Thymidine incorporation and proliferation of the primary SJL/L-sel.PLP20 T cell 
blasts. SJL/L-sel.PLP20 T cell blasts massively proliferate when stimulated with the mitogenic factor 
Concanavalin A. Cells have an elevated baseline spontaneous proliferation. Upon PLP139-151 stimulation, 
and compared to PPD, cells have a high proliferation. Data are presented as mean values of the 3H-dT 
incorporation measured as count per million (cpm) ± SD. 
 
tEAE induced with SJL/L-sel.PLP20 primary T cell blasts is shown in Figure III.5.9. SJL 
wild type and SJL/L-selectin-deficient mice develop disease on day 8-9 post injection 
and the peak of disease is on day 12 for both mouse groups. In SJL wild type mice, 
clinical symptoms scored decreased rapidly and mice completely recovered within 27 
days of observation. SJL wild type mice, instead, recovered more gradually within the 
observation period of 35 days. Following T cell blasts injection, as shown in the weight 
change graph, mice slightly loose their body weight and within three days they 
reconstitute it. Together with the appearance of the clinical symptoms, mice rapidly have 
lost body weight and the peak is on day 12, like the peak of severity of disease. 
Gradually both mouse groups gained body weight, but they did not fully recover within 
the observation period. 
Five different SJL/L-selectin-deficient primary cell lines were injected in SJL wild type 
and SJL/L-sel-/- mice and results were summarized in Table III.5.2. As for tEAE induced 
by primary SJL wild type PLP-specific T cell blasts, the results obtained were not 
conclusive. In fact, only two SJL/L-selectin-deficient primary T cell lines were able to 
transfer disease in SJL wild type and SJL/L-sel-/- mice. After the adoptive transfer of 
SJL/L-sel.PLP20 T cell blasts, SJL wild type mice developed EAE earlier than after 
injection of SJL/L-sel.PLP11 and SJL/L-sel.PLP21 blasts. SJL/L-selectin-deficient mice 
developed a delayed EAE when injected with SJL/L-sel.PLP11 T blasts compared to 
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SJL/L-sel.PLP20 primary T blasts, and SJL/L-sel.PLP21 T blasts did not transfer EAE in 
SJL/L-sel-/- mice. Concerning the severity of the disease, SJL/L-sel.PLP20 T blasts 
induced a more severe disease than SJL/Lsel.PLP11 and SJL/L-sel.PLP21 T blasts in SJL 
wt littermates. The disease score in SJL/L-selectin-deficient mice upon transfer of SJL/L-
sel.PLP20 primary T blasts was higher compared to the disease scored after injection of 
SJL/L-sel.PLP11 blasts. 
 
Figure III.5.9. SJL/L-sel.PLP20 primary T cell blasts induce tEAE in SJL wild type and SJL/L-sel-/- 
mice. SJL/L-sel.PLP20 T cell blasts induce equally severe tEAE in SJL wt and in SJL/L-sel-/- littermates. 
After injection, together with the appearance of the clinical symptoms, mice loose weight and are not able 
to reach their original body weight within the observation period. Data are presented as mean values of the 
day of onset of disease and weight change ± SD. One experiment of four. 
 
Day of onset of disease Severity of disease Primary SJL/L-
sel-/- primary 
PLP-specific T 
cell blasts 
injected 
Number of 
mice per 
group SJL wt mice SJL/L-sel-/- 
mice 
SJL wt mice SJL/L-sel-/- 
mice 
SJL/L-sel.PLP11 4 12.0±4.24 12.0±1.15 1.25±1.06 0.87±0.25 
SJL/L-sel.PLP13 3 No disease No disease 
SJL/L-sel.PLP18 3 No disease No disease 
SJL/L-sel.PLP20 3 8.0±0.0 9.66±0.75 * 3.0±1.0 2.0±1.0 
SJL/L-sel.PLP21 4 14.5±2.12 No disease * 1.50±0.70 No disease * 
 
Table III.5.2. tEAE comparison in SJL wild type and SJL/L-sel-/- mice induced by SJLL-sel-/- PLP-
specific primary T cell blasts. Mice developed disease only upon transfer of SJL/L-sel.PLP11 and SJL/L-
sel.PLP20 primary T cell blasts. Data are presented as mean values of the day of onset of disease and 
severity of disease ±  SD. * indicates significant difference. 
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To summarize, it was not possible to obtain reproducible data from tEAE experiments 
performed injecting SJL wild type or SJL/L-sel-/- PLP-specific T cell blasts. Some of the 
primary cell lines generated did not induce the development of EAE in SJL wt and/or 
SJL/L-selectin-deficient littermates. In addition, concerning the severity of disease 
scored, there is also variability: in fact SJL.PLP50 induced SJL/L-selectin-deficient mice 
to develop a more severe disease than their counterparts SJL wild type, and SJL/L-
sel.PLP20 cells induced higher severity of disease in SJL wild type mice than in SJL/L-
selectin-deficient animals. 
 
 
 
 
During the experiment, because they developed a too severe tEAE, or at the end of the 
observation period, mice were sacrificed and perfused to isolate the CNS (brain and 
spinal cord). In Figure III.5.10 the massive infiltration of CD45 positive cells into the 
meningeal compartment of SJL wild type and SJL/L-sel-/- mice injected with SJL/L-
sel.PLP20 primary T cell blasts is shown. CD45 positive cells also massively infiltrate 
the spinal cord in SJL wild type and SJL/L-selectin-deficient mice (Figure III.5.11) Mice 
were perfused on day 11 p.i. because they developed a severe disease (clinical score 3, 
paraparesis and incontinence). In Figure III.5.12 are shown CD45 positive infiltrates in 
SJL wt and SJL/L-sel-/- mice perfused on day 35 post injection with SJL/L-sel.PLP20 
primary blasts. CD45 positive cells massively accumulated in perivascular spaces in 
meningeal spaces and in cerebellum, and only few cells invaded the CNS parenchyma. 
No difference was seen in SJL wild type mice compared to SJL/L-selectin-deficient mice. 
In fact, in both mouse strains analyzed, CD45 positive T cells form inflammatory cuffs 
and accumulate in perivascular spaces. The same results were observed in the spinal cord 
of SJL wild type and SJL/L-selectin-deficient mice. In addition, as shown in Figure 
III.5.12, CD45 inflammatory cuffs were still detectable even if mice had fully recovered 
from disease (see Figure III.5.9). In conclusion, no apparent differences were identified 
when immunohistochemistry analyses performed on brain and spinal cord section of SJL 
wild type and SJL/L-selectin-deficient mice were compared. Furthermore, CD45 positive 
cells detection in mice sacrificed during the acute phase of disease (day 11) or during the 
phase of recover from disease (day35), did not present any difference in terms of cuffs 
formation and cell infiltration. 
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Figure III.5.10. Inflammatory CD45 positive cell infiltrates in brain. SJL wild type and SJL/L-selectin-
deficient mice injected with primary SJL/L-sel.PLP20 T cell blasts were sacrificed on day 11 because they 
developed too severe a disease (clinical score 3). CD45 positive cells massively infiltrate CNS in SJL wild 
type and SJL/L-selectin-deficient mice (meningeal compartment). On the right side an enlargement of the 
pictures on the left is shown. CD45 positive cells were detected by the monoclonal antibody M1/9. 
 
 
 
Figure III.5.10. Inflammatory CD45 positive cell infiltrates in spinal cord. SJL/L-sel.PLP20 primary T 
cells blasts induced high disease in SJL wt and SJL/L-sel-/- mice, which were perfused on day 11 (clinical 
score 3, foreleg paraplegia and incontinence) CD45 positive cells massively infiltrates CNS in SJL wild 
type and SJL/L-selectin-deficient mice (meningeal compartment). CD45 positive cells were detected by the 
monoclonal antibody M1/9; PECAM-1 positive cells were detected by the monoclonal antibody Mec13.3. 
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Figure III.5.12. Inflammatory CD45 positive cell infiltrates on day 35 p.i.. CD45 positive cells 
infiltrate plexus choroideus of SJL wild type and cerebellum of SJL/L-sel-/- mice injected with primary 
SJL/L-sel.PLP20 T cell blasts and form perivascular inflammatory cuffs as demonstrated by the 
colocalization with PECAM-1, which stains endothelial cells. CD45 positive cells were detected by the 
monoclonal antibody M1/9; PECAM-1 positive cells were detected by the monoclonal antibody Mec13.3. 
 
 
In conclusion, SJL/L-sel-/- T cells could be generated, but when they are restimulated in 
the presence of their specific antigen PLP139-151, there are still difficulties to obtain a 
sufficient number of blasts to inject and transfer EAE in SJL wild type and SJL/L-
selectin-deficient mice. For this reason, primary PLP-specific T cells from SJL wt and 
SJL/L-sel-/- mice were generated. As was shown in this thesis, contradictory results were 
obtained from tEAE tests performed using primary PLP-specific SJL wild type and 
SJL/L-sel-/- T cell blasts. In fact, the SJL wt primary blasts SJL.PLP52 and SJL.PLP58, 
and the SJL/L-selectin-deficient blasts SJL/L-sel.PLP13 and SJL/L-sel.PLP18 did not 
induce disease in recipients. In addition, the primary blasts SJL.PLP57 and SJL/L-
sel.PLP21 transferred disease in SJL wild type mice, but not in SJL/L-sel-/- littermates. 
When analyzed by immunohistochemistry, SJL wild type and SJL/L-selectin-deficient 
mice were positive for the presence of CD45 cells into the CNS, either when they had 
been injected with SJL wt PLP-specific primary blasts or SJL/L-sel-/- PLP-specific 
primary blasts. By flow cytometry, it was seen that on SJL wt and SJL/L-sel-/- PLP-
specific primary blasts were not detectable CD25 and CD122, and only few cells were 
positive for CD132, the IL-2R common gamma-chain. α4 integrin was slightly positive 
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on T cell blasts, and β1 and β7 integrins were not detectable. High levels of PSGL-1 were 
detected on SJL wt and SJL/L-sel-/- primary T cells. When the costimulatory molecules 
present on the surface of SJL wild type and SJL/L-selectin-deficient T cells were 
investigated, CD28 positive cells were detectable in SJL wt primary T cells and only 
intermediate values in SJL/L-sel-/- cells. Intermediate levels of CD152 and CD154, other 
two costimulatory molecules investigated and shown in this thesis, were detectable on 
both cell type analyzed, SJL wt and SJL/L-sel-/- primary T cells on day 2 post gradient. 
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III.6. Functional in vitro assays with SJL wild type and SJL/L-selectin-
deficient PLP-specific T cells: Trans-Endothelial Migration (TEM) 
assay 
After the phenotype of PLP-specific SJL wild type and SJL/L-sel-/- T cells was 
determined and after it was tested in vivo the ability of SJL/L-sel-/- T cell blasts to 
transfer EAE and the susceptibility of SJL/L-selectin-deficient mice to develop EAE, the 
goal was to test the migratory efficiency of SJL/L-selectin-deficient T cells across and 
endothelium. Although is well know that L-selectin is not involved in lymphocyte 
migration across the BBB endothelium, although it has already been exhaustively 
demonstrated that the capture of circulating lymphocytes at the BBB is mediated by α4 
integrin and ICAM-1, the migration rate of SJL/L-sel-/- PLP-specific T cells in 
comparison to SJL wild type T cells still had to be clarified. Trans-Endothelial Migration 
(TEM) assays were performed to answer this question. As described in Material and 
Methods, brain endothelial cells bEnd5 were plated on laminin coated Transwell® inserts 
for two days until they formed a confluent monolayer. At this point, 105 SJL wt and 
SJL/L-sel-/- primary T cells per insert were plated on the top of endothelial cells and 
allowed to migrate through the endothelium. After 4 hours, migrated cells were collected 
and counted at CASY® cell counter. First the efficiency of SJL.PLP46 and SJL/L-
sel.PLP7 primary T cells to migrate across an endothelium stimulated for 16h with the 
TNFα or across a non stimulated bEnd5 monolayer was assessed (Figure III.6.1). 45-
55% of T cells migrated across the endothelium and SJL/L-sel.PLP7 primary T cells 
migrated slightly more efficiently than SJL.PLP46 T cells. In particular, the SJL/L-
sel.PLP7 T cells migrated across a non stimulated bEnd5 monolayer significantly more 
than SJL.PLP46 cells. The same results were obtained when endothelial cells were 
stimulated with TNFα: SJL/L-sel.PLP7 cells migrated significantly more than their 
counterparts SJL.PLP46 primary T cells. No differences in the number of migrated T 
cells were seen when SJL/L-sel.PLP7 were added on the top of stimulated and non 
stimulated endothelial cells. Also the number of SJL.PLP46 primary T cells migrating 
across the bEnd5 monolayer did not differ in the presence or in the absence of TNFα 
stimulation. This experiment was repeated three times, but it was not possible to obtain 
reproducible data. In fact, when the migration of SJL wt and SJL/L-sel-/- T cells was 
tested in another test, different results were obtained (Figure III.6.2). SJL.PLP52 T cells 
migrated in general significantly more efficiently than SJL/L-sel.PLP14 cells. 
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Significantly higher was also the number of lymphocytes migrating across TNFα 
stimulated bEnd5 monolayer compared to non stimulated, in the presence or in the 
absence of antibodies specific for endothelial cell surface molecule. In this assay, the 
antibody MJ7/18, which binds to endoglin and does not affect the lymphocyte migration 
was used as a control. Thus, although blocking endoglin was not impaired the migration 
of SJL.PLP52 or SJL/L-sel.PLP14 primary T cells across the endothelium, blocking 
ICAM-1 using YNI a strong reduction in cell migration was observed (as has already 
been published in Reiss et al., 1999). Surprisingly, SJL.PLP52 T cells migrated better 
across non stimulated endothelium than through TNFα stimulated bEnd5 cells. 
 
 
 
 
Figure III.6.1. Trans-Endothelial Migration of SJL.PLP46 and SJL/L-sel.PLP7 primary T cells.  
SJL/L-sel.PLP7 primary T cells migrated significantly more efficiently than SJL.PLP46 T cells across 
stimulated and non stimulated bEnd5 monolayer. SJL/L-sel.PLP7 and SJL.PLP46 T cells did not migrate 
more efficiently across TNFα stimulated endothelial cells compared to non stimulated bEnd5 cells. Data is 
represented as mean values of migrated cells ± SD. Data relative to TNFα stimulated endothelial cells are 
shown in pink; data relative to non stimulated inserts is shown in blue. One experiment of four. * indicates 
statistical difference. 
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Figure III.6.2. Trans-Endothelial Migration of SJL.PLP52 and SJL/L-sel.PLP14 primary T cells. 
SJL.PLP52 T cells migrated more efficiently across stimulated and non stimulated endothelium. Blocking 
endoglin using the monoclonal antibody MJ7/18 did not impair the T cell migration efficiency. Blocking 
ICAM-1 with the monoclonal antibody YNI impaired the number of cells migrating through the 
endothelium. Data is represented as mean values of migrated cells ± SD. Data relative to TNFα stimulated 
endothelial cells are shown in pink; data relative to non stimulated inserts is shown in blue. One 
experiment of three. 
 
 
 
In conclusion, the data relative to the migration of SJL wild type and SJL/L-selectin-
deficient across an endothelium were not reproducible. In fact, SJL/L-sel.PLP7 and 
SJL/L-sel.PLP14 primary T cells migrated more efficiently than SJL.PLP46. When the 
SJL.PLP52 T cells were tested, was detected a high migration of cells also across the non 
stimulated endothelium (70%). Accordingly to what has already been published (Reiss et 
al., 1999), blocking ICAM-1 with the monoclonal antibody YNI there was a reduced 
migration of both SJL wt and SJL/L-sel-/- primary T cells across a TNFα stimulated and 
unstimulated bEnd5 monolayer. MJ7/18 was used as a control. In fact, the blocking of 
endoglin did not affect T cell migration, but rather this antibody was used to verify that 
the presence of an antibody on endothelial cell surface does not impair lymphocyte 
migration because of steric problems. 
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To summarize, SJL/L-selectin-deficient mice were generated backcrossing the original 
L-selectin-deficient mice (kindly provided by Prof. Dr. Mark Siegelman, Dallas, Texas, 
USA) into the EAE susceptible SJL mouse strain. The phenotype of SJL/L-sel-/- mice 
was investigated first by a comparison of the number of cells populating spleen, blood, 
peripheral and mesenteric lymph nodes. As was demonstrated in this thesis, SJL/L-
selectin-deficient mice were characterized by splenomegaly and by a reduction in 
lymphocytes into the PLN compared to SJL wild type littermates. The lymphocyte 
number in blood and MLN was not affected by the lacking of L-selectin on the 
lymphocyte surface. The phenotype of SJL/L-selectin-deficient mice was then 
investigated by flow cytometry and compared to the phenotype of SJL wild type and L-
selectin-deficient mice. The aim was to investigate the presence of the molecules 
involved in lymphocyte proliferation (IL-2 receptor), in lymphocyte rolling, adhesion and 
transmigration, such as integrins and PSGL-1, and was also investigated the presence of 
CD45RB on cell surface, to distinguish between naïve (CD45RB high) and 
effector/memory cells (CD45RB low). It showed a general impairment in detectable 
levels of CD25 and CD122 on the surface of SJL wt, SJL/L-sel-/- and L-selectin-deficient 
splenocytes and also on the surface of PLN and MLN lymphocytes. With the exception 
of β1 integrin, which was only present on the surface of SJL wt splenocytes and PLN 
lymphocytes, only intermediate levels of the integrin α4, α4β7, LFA-1 and β7 and were 
detectable on lymphocyte surface. High levels of CD45RB (naïve lymphocytes) and 
PSGL-1, which is involved in lymphocyte rolling on HEV, were detectable in all three 
mouse strains investigated, SJL wild type, SJL/L-sel-/- and L-selectin-deficient mice. As 
expected, L-selectin was present only on the surface of cells from SJL wild type mice.  
After the phenotype of SJL/L-selectin-deficient lymphocytes was determined by flow 
cytometry, experimental autoimmune encephalomyelitis was actively induced (aEAE) to 
investigate if L-selectin plays a role in the immunopathogenesis of disease and in the 
recruitment of inflammatory cells across the BBB. aEAE developed also in SJL/L-sel-/- 
mice, indicating that L-selectin is not required on effector cells for the development of 
EAE. Furthermore, SJL/L-sel-/- mice had a disease, in terms of severity of disease, 
comparable to SJL wild type littermates. By immunohistochemistry the presence of 
inflammatory CD45 positive cells within the CNS of EAE affected mice was 
investigated. In SJL wild type and in SJL/L-sel-/- mice, it was possible to identify massive 
perivascular inflammatory cuffs, in the brain and in the spinal cord. Next the ability of in 
vitro activated T cell blasts to transfer disease (tEAE) in mice lacking L-selectin was 
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investigated. tEAE was first induced by the passive transfer of T cell blasts of established 
SJL wt PLP-specific T cell lines. Again SJL/L-selectin-deficient mice developed disease 
as SJL wild type littermates. The establishment of SJL/L-selectin-deficient PLP-specific 
T cells lines failed. It was shown that these cell lines were difficult to cultivate in 
Germany and exhibited impairment in proliferation. The addition of mouse recombinant 
IL-2 and IL-15, which are cytokines involved in T cell proliferation, was not successful. 
It was shown in this thesis that the presence of mr IL-2 and mr IL-15 in cell culture 
medium did not increase the presence on cells surface of CD25 and CD122, which are 
components of the IL-2 receptor. The second part of the project was conducted in 
Switzerland where, for reasons still not clear, it was possible to generate and maintain 
SJL/L-selectin-deficient PLP-specific T cells in cultures in normal media, without the 
addition of mouse recombinants IL-2 and IL-15. SJL/L-sel-/- PLP-specific T cells were 
analyzed by flow cytometry and compared to SJL wt T cells. T cells were stained to 
detect the presence of IL-2 receptor molecules (CD25, CD122 and CD132) on their 
surface, the presence of integrins and PSGL-1, which are involved in lymphocyte rolling, 
adhesion and transmigration, and the presence of CD45RB, to distinguish naïve and 
memory cells. It was possible to detect CD25 and CD122 on few cells, and CD132 was 
detectable only using a particular antibody (TUGm2). It was shown that SJL/L-sel-/- 
primary T cells were only slightly positive for α4 integrin, but did not present β1 integrin 
on their surfaces. Both cell types were PSGL-1 high, but some differences were seen in 
CD45RB detection. In fact, the SJL wild type PLP-specific cells shown here were 
CD45RB high, naïve cells, whilst their counterparts SJL/L-sel-/- were effector/memory 
CD45RB low cells. Primary T cells were also investigated for the expression of 
costimulatory molecules. Only intermediate levels of CD152 and CD154 were present on 
the cell surface, CD28, instead, was better detectable on SJL wild type primary T cells. 
Consequently, SJL/L-selectin-deficient PLP-specific primary T cells were generated and 
restimulated in the presence of their specific antigen PLP aa 139-151. Unfortunately, cell 
proliferation was not successful and for this reason it was decided to transfer EAE using 
newly generated primary T cells. SJL wild type and SJL/L-sel-/- primary PLP-specific 
cells were generated and were reactivated in vitro and injected into syngenic recipients. 
Only some of the primary cells generated were able to induce disease in SJL wild type 
and SJL/L-selectin-deficient mice. When mice developed disease, it was not possible to 
obtain reproducible data. In fact, there was a high variability in the severity of the disease 
score and in the day of the onset of the disease. Immunohistochemistry investigations 
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have clearly shown that the presence of massive CD45 positive cell infiltrates into the 
CNS (brain and spinal cord) of SJL wt and SJL/L-sel-/- EAE affected mice. Thus, when it 
was evident that mice lacking L-selectin develop EAE and also T cells lacking CD62L 
on their surface can transfer disease in syngenic recipients, it was assessed, in 
comparison to SJL wt T cells, the ability of SJL/L-sel-/- primary T cells to cross the 
endothelium in vitro. Trans-Endothelial Migration (TEM) assays were then performed 
and primary T cells were induced to migrate through an endothelium, which had been 
previously stimulated or unstimulated with TNFα, a proinflammatory molecule. T cells 
were able to migrate through the endothelium and it was shown that blocking ICAM-1 
using an antibody (YNI), the migration of SJL wt and SJL/L-selectin-deficient primary T 
cells was reduced compared to the control antibody (MJ7/18). 
Finally, it is possible to conclude that L-selectin is not required for the recruitment of 
encephalitogenic cells across the BBB and for the immunopathogenesis of EAE. 
Furthermore, it can also be concluded that L-selectin is not required on the surface of 
CD4 positive T cells to transfer disease in recipient mice. 
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IV. DISCUSSION 
 
IV.1. Generation of SJL/L-selectin-deficient mice 
In order to investigate the role of L-selectin during the immunopathogenesis of 
experimental autoimmune encephalomyelitis (EAE) SJL/L-selectin-deficient mice were 
generate by backcrossing the L-selectin-deficient mice into the EAE susceptible SJL 
mouse strain. The first aim was to investigate the phenotype of the newly generated 
SJL/L-selectin-deficient mice. In the present study it could be demonstrated that in 
comparison with the SJL wild type littermates, the SJL/L-sel-/- mice have an increased 
splenic cellularity and a reduced number of lymphocytes homing to the peripheral lymph 
nodes. This confirms the phenotype for the L-selectin-deficient mice already published, 
showing an impairment in the number of lymphocytes in the peripheral lymph nodes 
(PLN) (Arbones et al., 1994; Catalina et al., 1996) and an increase in splenic cellularity 
(Steeber et al., 1996). In fact, lymphocytes lacking L-selectin on their surface cannot bind 
their specific ligands on high endothelial venules (HEV) and they cannot tether and roll 
on HEV in the peripheral lymph nodes (PLN). Interestingly, it is shown in this work that 
lymphocytes did not accumulate in the blood of SJL/L-sel-/- mice. The number of 
lymphocytes in the blood of SJL/L-sel-/- mice (2.2·107 lymphocytes/ml blood) did not 
differe compared to the amount of lymphocytes in the blood of SJL wild type littermates 
(2.5·107 lymphocytes/ml blood). It is shown that the lymphocytes accumulate in the 
spleen of SJL/L-selectin-deficient mice (5.1·108 cells) and their amount was significantly 
higher compared to the number of lymphocytes counted in the spleen of SJL wild type 
mice (2.3·108 cells). Within the spleen, circulating T cells extravasate and, driven by 
chemokines, they accumulate in the white pulp (Gunn et al., 1999; Forster et al., 1999). 
In the white pulp, T lymphocytes can encounter the antigen presenting cells and become 
activated (reviewed by Mebius and Kraal, 2005). This demonstrates that backcrossing L-
selectin-deficient mice into another mouse strain does not alter the main characteristics of 
the L-selectin-deficient mice, namely increased splenic cellularity and a reduced number 
of lymphocytes homing to the PLN. Next, lymphocytes from SJL/L-selectin-deficient 
mice were investigated by flow cytometry and compared to SJL wild type and L-selectin-
deficient mice. In particular, cell surface molecules involved in lymphocyte proliferation 
(IL-2 receptor) were investigated, as well as adhesion and transmigration of lymphocytes 
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through the endothelium (PSGL-1 and integrins). Interleukin (IL)-2 is a cytokine secreted 
by activated T cells and, via an autocrine pathway, binds to its receptor and induces T 
cell growth and proliferation. The CD4 positive activated T cells transiently express the 
high affinity IL-2 receptor, which is composed of the alpha-chain CD25, the beta-chain 
CD122 and the common gamma-chain CD132 on their surface (Minami et al., 1993). 
The expression of CD25 allows to distinguish between activated T cells, non-activated T 
cells and regulatory T cells, which are involved in the immunologic self tolerance. In 
fact, the high affinity IL-2 receptor is only shortly present on the cell surface of activated 
T cells after antigen presentation, whilst it is constitutively present on the surface of 
regulatory T cells (Almeida et al., 2002). Non-activated T cells, in contrast, do not 
express CD25 on their surface, but show the intermediate affinity IL-2R, which is 
composed by beta- and common gamma-chain (Robb et al., 1981). In this thesis it is 
shown that only a few (1-5%) percentage of freshly isolated naïve Thy1.2 positive T cells 
isolated from spleen and PLN of SJL wild type, SJL/L-sel-/- and L-selectin-deficient stain 
positive for CD25 and CD122 on their surface. The IL-2 receptor beta-chain CD122, is 
shown to be present on the surface of a few percentage of cells, but high levels of 
CD132, the common gamma-chain, are detectable on Thy1.2 positive T cells in all cell 
populations analyzed. The low levels of CD25, compared to CD122 and CD132, suggest 
that the Thy1.2 positive cells analyzed are naïve cells and present the intermediate 
affinity IL-2 receptor on their surface. Together with the molecules involved in T cell 
proliferation, the molecules involved in lymphocyte rolling, such as PSGL-1 were also 
investigated. In addition, molecules mainly involved in adhesion and transmigration, 
such as integrins were studied. PSGL-1, which is a L-selectin ligand and mediates 
leukocyte-endothelium and leukocyte-leukocyte interactions in vivo (Sperandio et al., 
2003), was shown to mediate the rolling of activated T cells on the vascular endothelium 
(Atarashi et al., 2005). In fact, whilst naïve lymphocytes express L-selectin on their 
surface, activated lymphocytes do not present L-selectin on their surface, they require 
other molecules to roll along the endothelium. Furthermore, it was shown that also E- 
and P-selectin do not mediate lymphocyte rolling along the blood-brain barrier (BBB) 
during inflammation (Engelhardt et al., 1997), but rather α4 integrin and PSGL-1 are 
required to mediate lymphocyte rolling (Kerfoot and Kubes, 2002). The α4 integrins 
(α4β1 and α4β7) and the leukocyte-function associated antigen-1 (LFA-1) form stable 
bonds with their respective ligands on the endothelium and allow the circulating 
lymphocytes to firmly adhere to the endothelium (Lawrence et al., 1991; Berlin et al., 
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1995). In fact, the chemokines CCL19 and CCL21, which are released by the BBB 
endothelium, were shown to bind to their G-coupled receptor (CCR7) on the surface of 
the rolling lymphocytes in vitro (Alt et al., 2002). By intravital microscopy it was 
demonstrated that G-protein mediated signalling is required for the firm arrest of 
encephalitogenic T cells in the spinal cord (Vajkoczy et al., 2001). Via an inside-out 
signalling, the chemokine receptor CCR7 activates the integrins on the lymphocyte 
surface and integrins are now able to mediate the firm adhesion of lymphocytes to the 
endothelium.  
In this thesis it is shown that high levels of PSGL-1 are detected on the surface of the SJL 
wild type, SJL/L-selectin-deficient and L-selectin-deficient lymphocytes, in particular on 
the surface of PLN lymphocytes. Staining for the integrins is positive, suggesting that 
breeding L-selectin-deficient mice into the SJL wild type mouse strain did not alter the 
lymphocyte characteristics and the expression of surface molecules. In general, the newly 
generated SJL/L-selectin-deficient mice resemble the peculiarities of the original L-
selectin-deficient mice reported in the literature (Arbones et al., 1994; Catalina et al., 
1996). 
 
 
 
 
IV.2. active experimental autoimmune encephalomyelitis (aEAE) 
Experimental autoimmune encephalomyelitis is an animal model for the study of the 
pathogenesis of multiple sclerosis, an inflammatory demyelinating autoimmune disease 
of the central nervous system (CNS) in humans. As it is shown in this thesis, after active 
immunization with the myelin component proteolipid protein (PLP), SJL wild type and 
SJL/L-selectin-deficient mice develop aEAE, which is triggered by autoaggressive PLP-
specific CD4 positive T cells. It is also shown that the severity of the disease in the 
SJL/L-selectin-deficient mice is comparable to the one scored in the SJL wild type mice. 
In the SJL mouse strain, EAE is induced by active immunization with the myelin 
component proteolipid protein (PLP). In particular, the encephalitogenic determinant of 
PLP was shown to be localized at the amino acids 139-151 (Tuohy et al., 1989). After 
immunization, naïve lymphocytes are activated in the secondary lymphoid organs and 
become effector/memory T cells (Krakowski and Owen, 2000). Effector/memory 
autoaggressive T cells accumulate at the blood-brain barrier (BBB), where they induce 
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inflammation, and accumulate in the CNS perivascular spaces (Cross et al., 1990). There, 
the autoaggressive CD4 positive T cells encounter their specific antigen presented by the 
perivascular macrophages and are re-activated (reviewed by Engelhardt and Ransohoff, 
2005). Migratory effector/memory T cells display a distinct phenotype. It was shown that 
the lymphocytes involved in the early stages of aEAE are CD4 positive effector/memory 
cells (CD45RB low), which present high levels of CD44 and high levels of LFA-1 (αLβ2) 
and VLA-4 (α4β1) integrins on their surface (Zeine and Owens, 1992; Engelhardt et al., 
1995; Engelhardt et al., 1998). Using an anti VLA-4 (very late antigen-1) antibody it 
could be demonstrated that the binding of lymphocytes to brain vessels of EAE affected 
rats in vitro and accumulating in the CNS in vivo was inhibited (Yednock et al., 1992). 
Based on those observations, it was thought that blocking lymphocyte surface molecules 
with specific antibodies could be used to interfere with the regular onset of disease. Later 
on, the anti α4 integrin antibodies were tested in EAE affected mice and were able to 
reduce the severity of the disease (Brocke et al., 1999). Antibodies blocking LFA-1 
(leukocyte-function associated antigen-1) were also developed and could be used to 
interfere with the development of EAE. The results were not conclusive. In fact, on the 
one side some studies have shown the efficacy of the antibodies directed against LFA-1 
(Gordon et al., 1995; Lin et al., 1998), on the other side it was demonstrated that the 
severity of the disease increased upon treatment with anti LFA-1 antibodies (Welsh et al., 
1993). The selectin family proteins were also investigated to elucidate their role in 
inflammation and during the development of EAE. It was shown that E- and P-selectin 
could not be detected on the BBB endothelium and that antibodies directed against E- 
and P-selectin failed to prevent the recruitment of inflammatory cells across the BBB and 
the development of EAE (Engelhardt et al., 1997). In contrast, there is another study 
where the presence of P-selectin on the BBB endothelium was demonstrated (Kerfoot 
and Kubes, 2002). Kerfoot and Kubes, in fact, have shown by blocking P-selectin with a 
specific antibody, that it was possible to reduce the trafficking of encephalitogenic 
lymphocytes across the BBB. The role of L-selectin in inflammation was first 
investigated, in vivo, by the administration of anti L-selectin (CD62L) antibodies. It was 
shown that, blocking L-selectin in a peritonitis model, there was a reduced migration of 
neutrophils, monocytes and lymphocytes within the inflamed peritoneum (Kunkel and 
Ley, 1996). Using a specific anti CD62L antibody for rats, the role of L-selectin diring 
the development of active EAE in Lewis rats was investigated (Archelos et al., 1998). 
Blocking L-selectin reduced the migration of lymphocytes to the secondary lymph nodes 
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and it was therefore reduced the lymphocyte activation. Thus, the administration of an L-
selectin antibody resulted in an amelioration of the severity of the disease and in a 
reduction of the inflammatory cuffs within the CNS in Lewis rats. In order to be 
effective, the antibody therapy requires continuous administration of antibodies during 
the observation time. In addition, the antibody titre needs to be high enough in the blood 
to be efficient and bind to its target. With the generation of L-selectin-deficient mice, the 
experimental procedure is simplified and the administration of antibodies in vivo is 
avoided. The generation of L-selectin-deficient mice provides important informations 
about the role of L-selectin during inflammation. In fact, it was demonstrated that L-
selectin-deficient mice have an impairment in monocyte, neutrophil and lymphocyte 
migration into the chronically inflamed peritoneum (Tedder et al., 1995). Furthermore, it 
was shown that the L-selectin deficient mice, because of the reduced lymphocyte 
migration into the PLN, had a significantly reduced mortality upon lipopolysaccharide 
(LPS) administration compared to the wild type mice (Tedder et al., 1995). In delayed-
type hypersensitivity (DTH), an altered cytokine production, a reduced footpad and ear 
swelling and an impaired T cell proliferation in L-selectin mice was reported, suggesting 
that L-selectin plays an active role in the generation of primary immune responses during 
inflammation (Tedder et al., 1995; Catalina et al., 1996). Also, the existence of L-
selectin-independent compensatory mechanisms responsible for the priming and the 
activation of lymphocytes are suggested (Xu et al., 1996). In addition, the L-selectin-
deficient mice, compared to wild type littermates, were demonstrated to have a reduced 
migration of neutrophils, monocytes and lymphocytes into inflammatory sites during 
contact hypersensitivity (Catalina et al., 1996). In an animal model of asthma performed 
in L-selectin-deficient mice, it was shown that L-selectin takes part in lymphocyte 
migration to the lungs during inflammation (Keramidaris et al., 2001).  
In this thesis it is shown that SJL/L-selectin-deficient mice develop active EAE which is 
indistinguishable from the disease developed by SJL wild type mice. In fact, no 
differences were seen in the day of onset of the disease and in the severity of disease in 
SJL/L-sel-/- compared to wild type mice. This might suggest that in the absence of 
CD62L there are L-selectin-independent compensatory mechanisms playing a role in the 
priming and in the activation of lymphocytes. The compensatory mechanismslead to the 
activation of L-selectin-deficient naïve lymphocytes and they can become autoaggressive 
T cells.  
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However, it was previously reported that C57Bl/6-CD62L-deficient MBP-TCR 
transgenic mice did not develop EAE following active immunization with MBP (myelin 
basic protein) peptide (Grewal et al., 2001). These mice were additionally transgenic for 
the myelin basic protein T cell receptor (MBP-TCR) known to induce severe EAE 
shortly after immunization with MBP (Lafaille et al., 1994). Furthermore, it was shown 
that in C57Bl/6-CD62L-MPB-TCR transgenic mice the CNS was not damaged and, 
unusually for the C57Bl/6 mouse strain, the myelin structure was intact. It is known, in 
fact, that the CNS in the C57Bl/6 mouse strain is characterized by demyelination and 
damage upon immunization with MPB peptide. In the SJL/L-selectin-deficient EAE 
affected mice, in this study, it was possible to find inflammatory cells not only in the 
perivascular spaces, but also in the CNS parenchyma. On the opposite site, in the MBP-
TCR transgenic C57Bl/6-CD62L-deficient mice the CD45 positive inflammatory cells 
were only detected in the perivascular spaces, while in the MBP-TCR transgenic 
C57Bl/6 wild type mice CD45 positive cells could be detected in the CNS parenchyma 
(Grewal et al., 2001). Taken together, it is evident that the SJL and the C57Bl/6 mice 
have different peculiarities and differences, which generate completely opposite results. 
In addition, it is clear that the lack of L-selectin on the lymphocyte surface of L-selectin-
deficient mice has not the same effect as the antibody inhibition of L-selectin in Lewis 
rats (Archelos et al., 1996). In rats, an amelioration of the severity of the disease and a 
reduction in the formation of inflammatory cuffs upon antibody treatment was seen. In 
the MBP-TCR transgenic C57Bl/6-CD62L-deficient mice EAE did not develop upon 
immunization with MBP peptide while in contrast, the SJL/L-selectin-deficient mice 
develop EAE, as their wild type counterparts, following immunization with PLP peptide. 
Thus, it is necessary to further investigate the role of L-selectin in the development of 
active EAE. In fact, is still necessary to verify whether L-selectin is required for the onset 
of EAE and where lymphocytes are primed and become autoaggressive T cells. It was 
shown that L-selectin-deficient mice have a reduced number of lymphocytes homing the 
PLN (Arbones et al., 1994; Catalina et al., 1996) and an increased splenic cellularity 
(Steeber et al., 1996), thus the spleen seems to be the location where naïve cells are 
activated and differentiate. 
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IV.3. Passive transfer of experimental autoimmune encephalomyelitis 
(tEAE)  
In this thesis, it is shown that in vitro activated PLP-specific T cell blasts are able to 
induce disease not only in SJL wild type mice, but also in SJL/L-selectin-deficient 
littermates. It is shown that mice developed tEAE in 8-13 days upon injection of T cell 
blasts. 
From the literature it is known that, after activation of encephalitogenic T cells in vitro 
and subsequent injection into mice in order to transfer EAE, inflammatory cells do not 
need to enter the lymph nodes to be activated, but rather, encephalitogenic T cells can 
directly circulate within the blood, reach the BBB and induce inflammation (Wekerle et 
al., 1986; Hickey and Kimura, 1988). It was shown that the inflamed CNS produces 
chemokines (CCL19 and CCL21) which, attracting CD45 positive cells, contribute to the 
maintenance of neuroinflammation and to the development of EAE (Columba-Cabezas et 
al., 2003). In Lewis rats, it was demonstrated that there are two waves of autoreactive T 
cells accumulating in the CNS following adoptive transfer (Flügel et al., 2001). CD4 
positive autoaggressive MBP-specific T cells, transgenic for green fluorescent protein 
(GFP), were injected into Lewis rats and tracked during their migration through the BBB 
into the CNS. Alexander Flügel has shown that the first group of encephalitogenic CD4 
positive MBP-GFP T cells penetrates the CNS few hours after adoptive transfer and 
accumulates in the CNS parenchyma and in the meningeal compartment. These cells 
induce CNS inflammation and prepare the environment for the second wave of cells. The 
second wave of autoreactive T cells is composed by lymphocytes which, upon transfer, 
recirculated through the lymph nodes, acquired migratory capacity and re-expressed 
CCR7 on their surface. With this characteristics, these T cells can easily accumulate in 
the CNS, amplify the neuroinflammation and induce EAE development (Flügel et al., 
2001). The phenotype of in vitro activated encephalitogenic CD4 positive T cells was 
extensively investigated in the past. It was shown that murine CD4 positive infiltrating 
cells display a typical effector/memory phenotype, which is CD45RB low, LFA-1 high, 
VLA-4 high and L-selectin low (Engelhardt et al., 1998). It was as well shown that L-
selectin is not expressed on the surface of activated encephalitogenic T cells at the time 
of injection (Laschinger and Engelhardt, 2000) because it is cleaved from the cell surface 
upon activation (Jung et al., 1988). In addition, it was demonstrated that, in vivo, 
encephalitogenic T cells can re-express L-selectin on their surface within three days after 
injection (C.Alt, PhD thesis, 2003). Thus, the possible existence of L-selectin-
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independent mechanisms for T cell activation and the re-expression of L-selectin in vivo 
within three days following injection, could explain how SJL/L-selectin-deficient mice 
develop EAE upon adoptive transfer of SJL wild type PLP-specific encephalitogenic T 
cell blasts. In addition, from the literature it is known that blockade of L-selectin with the 
monoclonal antibody MEL-14 was not successful in the attenuation of tEAE in 
(PLxSJL)F1 mice (Brocke et al., 1999). It was shown that even after several injections of 
MEL-14, the (PLxSJL)F1 mice developed disease comparable to the control mice. It has 
to be taken in consideration that in the literature it was also reported that MBP-TCR 
transgenic C57Bl/6-CD62L-deficient mice did not develop EAE upon passive transfer of 
in vitro activated T cell blasts (Grewal et al., 2001). In fact, it was demonstrated that 
MBP-TCR transgenic C57Bl/6-CD62L-deficient mice did not develop tEAE either 
following wild type encephalitogenic T cell blasts transfer, or upon injection of L-
selectin-deficient autoreactive T blasts. Thus, Grewal et al., concluded that L-selectin is 
required on non-lymphocytes. As it is shown in this thesis, in vitro activated SJL wild 
type T cell blasts were able to induce disease in SJL/L-selectin-deficient mice, 
suggesting that in the SJL background L-selectin is not required for the recruitment of 
encephalitogenic T cells across the BBB. 
 
 
 
 
IV.4. Generation of SJL/L-selectin-deficient PLP-specific T cell lines 
While our laboratory was still located in Germany, it was not possible to establish and 
cultivate SJL/L-selectin-deficient PLP-specific T cell lines. For reasons that are not 
understood, in Switzerland SJL/L-selectin-deficient PLP-specific T cells can be 
maintained in culture, but, compared to the SJL wild type T cell lines, they have an 
impaired proliferation and it is not possible to perform a tEAE test with these cells.  
The first hypothesis was that CD4 positive T cells had an impairment in the proliferation 
pathway. In the literature, an impairment in cytokine production and T cells response 
during delayed-type hypersensitivity (DTH) in L-selectin-deficient mice was reported 
(Xu et al., 1996). In a short term DTH assay, it was demonstrated that interleukin (IL)-2 
secretion and T cell proliferation were compromised in L-selectin-deficient mice. In fact, 
due to the reduced migration of lymphocytes to the PLN, T cells were less activated in L-
 92
                                                                                                                                       Discussion 
selectin-deficient mice compared to wild type animals, and therefore they were only able 
to secrete low levels of IL-2. IL-2 is known to be a cytokine secreted by CD4 T cells and 
that stimulates the proliferation of CD4 T cells depending on their activation state 
(Ashwell et al., 1986). Furthermore, it was demonstrated that IL-2 plays a role in the 
development and in the survival of memory CD4 positive cells (Dooms et al., 2004). It 
was shown that CD4 positive cells can undergo apoptosis in the absence of IL-2, and that 
the IL-2 producing T cells diminish in aged individuals (Haynes et al., 1999). Mouse 
recombinant IL-2 and IL-15 were reported to stimulate proliferation and survival of 
activated T cells in vivo and in vitro (Seder, 1996; Li et al., 2001). IL-15 (Grabstein et al., 
1994) has its own specific alpha-chain, but it shares CD122 and CD132 (intermediate 
affinity IL-2 receptor) with IL-2 (Giri et al., 1995). In agreement with the literature, in 
the present study SJL/L-selectin-deficient PLP-specific T cells cultivated in the presence 
of mouse recombinant IL-2 and IL-15 could survive longer in culture than cells 
cultivated in the absence of those recombinants. It was also shown that on SJL/L-sel-/- T 
cells, which were cultivated in the presence of mouse recombinant IL-2 and IL-15, CD25 
and CD122 were only slightly detectable, suggesting that T cells did not properly 
proliferate. In contrast, it was shown that in MBP-TCR transgenic C57Bl/6-CD62L-
deficient mice the proliferative response of CD4 positive T cells was normal (Grewal et 
al., 2001). It was shown that the frequency of responding T cells and the T cell 
specificity for the MBP antigen in vitro was not defective in C57Bl/6-CD62L-deficient 
compared to wild type mice. However, despite their ability to proliferate in response to 
their specific antigen in vitro, these cells were not able to transfer disease in syngeneic 
recipients. In the present work, instead, it is shown that, in the presence of their specific 
antigen PLP (10µg/ml), the proliferation of SJL/L-selectin-deficient T cells, derived from 
the spleen of PLP-primed mice, is reduced compared to cells from wild type mice.  
Thus, it is clear that in both SJL/L-selectin-deficient mice and in MBP-TCR transgenic 
C57Bl/6-CD62L-deficient mice there is an immune response and the activation of T cells 
might depend on L-selectin-independent mechanisms. 
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IV. 5. tEAE induced with primary PLP-specific T cell blasts 
In the present study it is shown that SJL/L-selectin-deficient T cell lines are established, 
their proliferation is impaired compared to the SJL wild type PLP-specific T cells. Due to 
this fact, EAE was induced by adoptive transfer of primary PLP-specific T blasts. The 
presence of IL-2 receptor molecules and costimulatory molecules on the surface of 
SJL/L-selectin-deficient PLP-T cells was investigated. Interleukin (IL)-2 is a cytokine 
responsible for the proliferation of T cells. Following the binding of the T cell receptor 
(TCR) with its antigen presented by MHC class II molecules on antigen presenting cells 
(APC), IL-2 is produced and secreted by T cells. Via an autocrine pathway, IL-2 binds to 
its receptor, which is composed by three chains: CD25, CD122 and CD132. CD122 
(beta-chain) and CD132 (common gamma-chain) are constitutively present on the T cell 
surface. CD25 (alpha-chain) expression, instead, is enhanced upon T cell activation. 
Binding of TCR and MHC class II molecules is not sufficient to fully activate T cells and 
to trigger the expression of CD25 on the T cell surface. In fact, a costimulatory signal, 
which is delivered by the CD28-B7 interaction, is necessary (Cerdan et al., 1992; Fraser 
et al., 1992). CD28 is a costimulatory molecule on the surface of T cells and interacts 
with the B7 molecules on the APC. The interaction CD28-B7 was shown to amplify the 
signal generated by TCR and APC (Viola and Lanzavecchia, 1996; Wulfing and Davis, 
1998). In fact, it could be shown that the TCR-mediated stimulation in the absence of 
CD28 mediated costimulation induces T cell anergy and results in the production of a 
small amount of IL-2 (Powel et al., 1992; Harding et al., 1992). The antagonist of CD28 
is CD152 or CTLA-4 (cytotoxic T lymphocyte associated protein-4). CTLA-4, which is 
also present on the surface of T cells, was demonstrated to have inhibitory effects on IL-2 
production and T cell proliferation (Bluestone, 1997). In addition, CD152 was shown to 
be sequestered intracellularly and to be exposed on the surface of T cells following 
activation (Perkins et al., 1996). The role of CD28 and CD152 was investigated by the 
administration of specific antibodies in vivo in EAE. It was shown that the blockade of 
CD28 during in vitro activation of encephalitogenic T cells or during the onset of EAE 
resulted in an attenuation of the severity of the disease in C57Bl/6 mice (Perrin et al., 
1999). In addition, C57Bl/6-CD28-deficient mice were seen to be protected from the 
development of active EAE (Chang et al., 1999). It has to be mentioned that recently a 
violent reaction to the monoclonal anti CD28 antibody in humans was reported. In March 
this year, during a clinical trial, the reaction against a new CD28 antibody developed by 
healthy volunteers so dramatic, that the trial was promptly interrupted and the affected 
 94
                                                                                                                                       Discussion 
volunteers were kept at the hospital. Blocking CTLA-4, instead, resulted in the opposite 
effect. In C57Bl/6 mice, the administration of anti CD152 antibodies exacerbates the 
disease and enhances the mortality (Perrin et al., 1996), whilst in SJL mice it was shown 
to enhance T cell reactivity (Karandikar et al., 2000). In the literature, no impairment in 
the expression of CD28 or CTLA-4 on the T cell surface in the absence of L-selectin is 
reported. However, in the present thesis it is shown that intermediate levels of CD152 
were detected on SJL/L-selectin-deficient  and SJL wt T cells, while the presence of 
CD28 was slightly reduced on the surface of SJL/L-selectin-deficient T cells compared to 
the wild type, but this did not interfere with their ability to induce tEAE. In fact, it is 
shown that in vitro activated SJL/L-selectin-deficient T cells could induce EAE in 
syngeneic recipients and massive CD45 positive cell infiltrates were detected in the brain 
and in the spinal cord of SJL/L-selectin-deficient mice. However, in a previous study, it 
was demonstrated that C57Bl/6-CD62L-deficient mice did not develop EAE upon 
adoptive transfer of MBP-specific C57Bl/6 wild type or L-selectin-deficient T cell blasts 
(Grewal et al., 2001). To test whether the expression of L-selectin on T cells is required 
to induce EAE, Grewal and Flavell transferred in vitro activated T cells in sublethally 
irradiated non MBP-TCR transgenic C57Bl/6 wild type or CD62L-deficient mice. Wild 
type C57Bl/6 mice developed tEAE even when injected with C57Bl/6-CD62L-deficent T 
cells, indicating that L-selectin is not required on T cells to transfer the disease. The 
C57Bl/6-CD62L-deficent mice, instead, did not develop EAE symptoms, suggesting that 
L-selectin might be required on other cells than T cells. Therefore, spleens from 
C57Bl/6-CD62L-deficent mice were homogenized and depleted of their T cell population 
and injected into MBP-TCR transgenic C57Bl/6 wild type and C57Bl/6-CD62L-deficent 
mice. It was shown that, following injection of antigen presenting cells (APC), MBP-
TCR transgenic C57Bl/6-CD62L-deficent mice developed EAE. To identify which APC 
transferred the disease in the recipient mice, C57Bl/6-CD62L-deficent mice were 
reconstituted with macrophages from wild type C57Bl/6 mice before aEAE was induced 
by immunization with MBP peptide.  It could be demonstrated that C57Bl/6-CD62L-
deficient MBP-TCR transgenic mice develop acute tEAE following the injection of wild 
type activated macrophages and, by immunohistochemistry, CNS demyelination was 
detected. Grewal and Flavell have also shown that macrophages from C57Bl/6-CD62L-
deficient mice did not induce EAE symptoms and demyelination in syngeneic recipients. 
When the effector functions of C57Bl/6-CD62L-deficient macrophages were tested in 
vitro, any abnormality could be seen. In fact, C57Bl/6-CD62L-deficient macrophages 
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produced proinflammatory cytokines and chemokines in vitro as effective as the wild 
type macrophages. Thus, it was suggested that the absence of EAE symptoms in 
C57Bl/6-CD62L-deficient mice was due to local events involving L-selectin and was not 
due to the impaired activation of effector cells.  
In summary, it was not possible to obtain conclusive results from the data obtained using 
SJL/L-selectin-deficient mice, which were shown in this thesis, and from the data 
obtained by Richard Flavell using C57Bl/6-CD62L-MBP-TCR transgenic mice,. In 
addition, the opposing results obtained indicate that further investigation are required to 
elucidate the role of L-selectin during the development of tEAE. 
 
 
 
 
IV.6. Functional in vitro assays with SJL wild type and SJL/L-selectin-
deficient PLP-specific T cells: Trans-Endothelial Migration 
It was demonstrated in vivo that SJL/L-selectin-deficient mice are able to develop aEAE 
and that T cells, generated from SJL wt or from SJL/L-sel-/- mice, can transfer the disease 
to syngeneic recipients. The next question addressed was the migration efficiency of 
SJL/L-selectin-deficient primary T cells across a brain endothelium in vitro. 
The pivotal role of ICAM-1 in the diapedesis of lymphocytes across the endothelium in 
the periphery and in the CNS was demonstrated in vitro using rat endothelial cells 
(Adamson et al., 1999) and mouse brain endothelial cells (Reiss et al., 1998; Lyck et al., 
2003). The central role of LFA-1 in the transmigration of encephalitogenic T cells across 
the BBB was shown by intravital microscopy in healthy SJL mice (Laschinger et al., 
2002). In addition, ICAM-1 was seen in vivo to be involved in lymphocyte interaction 
with the CNS endothelium during inflammation, such as EAE (Steffen et al., 1994) and 
MS (Sobel et al., 1990), and in vitro (Reiss et al., 1998; Reiss and Engelhardt, 1999). In 
particular the intracellular domain of ICAM-1 is essential for the lymphocyte migration 
and ICAM-1 mediates intracellular signalling which facilitates the transmigration of CD4 
positive T cells across the brain endothelium (Greenwood et al., 2003; Lyck et al., 2003). 
In fact, it was shown that ICAM-1 intracellularly activates Rho-A in vitro (Adamson et 
al., 1999), and that blockade of the Rho-A dependent pathway inhibits the recruitment of 
lymphocytes into the inflamed CNS in vivo in Biozzi mice (Walters et al., 2002).  
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In this thesis SJL/L-selectin-deficient primary PLP-specific T cells were shown to 
migrate in vitro across an endothelial monolayer, even in the absence of proinflammatory 
stimuli such as TNF-α. Because of the importance of ICAM-1 in the migration of 
lymphocytes across the endothelium, the endothelial monolayer was pre-treated with an 
antibody directed against ICAM-1. According with the results already reported in the 
literature, in the presence of anti ICAM-1 antibodies only 20-30% of the T cells used in 
the assay migrated across the endothelium in comparison to the control in the absence of 
antibodies. This suggests that the absence of L-selectin does not interfere with the 
migration of lymphocytes nor with the presence of ICAM-1 on their surface. In addition, 
it was already shown in vivo that SJL/L-selectin-deficient lymphocytes can cross the 
BBB and penetrate the CNS. 
 
 
 
 
To summarize, the exact role of L-selectin during CNS inflammation still needs to be 
clarified. In the past, the role of L-selectin in the pathogenesis of EAE was only 
addressed using antibodies blocking L-selectin and the results were not conclusive. In 
fact, anti L-selectin antibodies could only prevent the development of aEAE (Archelos et 
al., 1998), but not the onset of tEAE (Brocke et al., 1999). The administration of a 
specific anti L-selectin antibody after the induction of aEAE could significantly delay 
and suppress the disease in Lewis rats (Archelos et al., 1998). In addition, it was shown 
that the same antibody, called HLR3, caused a dramatic reduction in lymphocyte homing 
to the draining popliteal lymph nodes and a reduced T cell activation compared to the 
control rats. The administration of the HRL3 antibody during the complete observation 
time only a partially reduced the severity of the disease in Lewis rats upon adoptive 
transfer of encephalitogenic in vitro activated MBP-specific T cells. It was assumed that 
the inhibition of the disease was caused by the absence of L-selectin on the lymphocyte 
surface. In fact, blockade of L-selectin impaired lymphocyte trafficking to the PLN. 
Thus, it was demonstrated that, in Lewis rats, L-selectin is involved in the pathogenesis 
of EAE. In contrast, in (PLxSJL)F1 mice the blockade of L-selectin with the monoclonal 
antibody MEL-14 did not alter the course of the disease (Brocke et al., 1999). While 
antibodies directed against α4 integrin and CD44 were able to reduce the infiltration of 
inflammatory cells in the CNS and prevented the generation of inflammatory cuffs in the 
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CNS parenchyma, in vivo administration of MEL-14 could not prevent the development 
of adoptive transfer of EAE. In fact, continuous injections of MEL-14 following passive 
transfer of encephalitogenic T cells could not interfere with the disease progression in 
(PLxSJL)F1 mice. Furthermore, antibodies against α4 integrin and CD44 directly blocked 
the migration of autoaggressive T cells into the CNS in (PLxSJL)F1 mice. It was 
hypothesised that these antibodies blocked not only the first influx of T cells, which 
occurs in the first few hours after the injection of in vitro activated encephalitogenic T 
cells into syngeneic recipients, but could block also the second influx of activated 
lymphocytes in the CNS. Therefore, from the data obtained in (PLxSJL)F1 mice it was 
concluded that L-selectin has no effect in the immunopathogenesis of EAE and is not 
involved in the secondary recruitment of lymphocytes in the CNS (Brocke et al., 1999). 
Afterwards, the role of L-selectin in the development of EAE was studied using L-
selectin-deficient mice. Richard Flavell and his collaborators, using C57Bl/6-CD62L-
deficient mice transgenic for the myelin basic protein-T cell receptor (MBP-TCR), have 
shown that L-selectin is required on the effector cells for the development of EAE, and it 
is required for the entry of inflammatory cells into the CNS parenchyma and for the 
demyelination of the CNS (Grewal et al., 2001). They have shown that the absence of L-
selectin prevented the development of EAE in their mouse model, but did not affect the 
development, the activation and the differentiation of encephalitogenic T cells. In fact, 
even if MBP-TCR transgenic C57Bl/6-CD62L-deficient mice did not develop EAE 
symptoms, inflammatory cuffs were detected in the perivascular spaces of the CNS. So, 
they concluded that the lack of EAE cannot be due to an inhibition of the lymphocyte 
migration to the CNS perivascular spaces, but is rather due to the lack of autoimmune T 
cell migration in the CNS parenchyma. Richard Flavell suggested three hypotheses to 
explain the fact that MBP-TCR transgenic C57Bl/6-CD62L-deficient mice did not 
develop EAE. The first hypothesis is that the lack of L-selectin could be responsible for 
the differentiation of T cells into Th2 cells and not into Th1 cells. However, it was shown 
that MBP-TCR transgenic C57Bl/6-CD62L-deficient mice developed encephalitogenic T 
cells, which were able to proliferate and to produce cytokines and to differentiate into 
Th1 cells as good as their wild type counterpart. The second hypothesis is that the lack of 
L-selectin could suppress the immune response. The data, by contrast, demonstrated that 
the immune response in MBP-TCR transgenic C57Bl/6-CD62L-deficient mice in vivo 
and in vitro was not impaired compared to their wild type littermates. The last hypothesis 
suggests that the absence of CD62L inhibits the homing of lymphocytes to the CNS and 
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their ability to induce demyelination. A precise immunohistochemical analysis revealed 
that in MBP-TCR transgenic C57Bl/6-CD62L-deficient mice, as in the wild type 
littermates, the infiltrating perivascular cells are T cells, B cells and macrophages. Thus, 
it was clear that the failure of MBP-TCR transgenic C57Bl/6-CD62L-deficient 
encephalitogenic T cells to migrate within the CNS parenchyma prevented the 
development of EAE, not a general deficiency in lymphocyte migration to the CNS. To 
explain why encephalitogenic T cells do not migrate within the CNS parenchyma in the 
absence of L-selectin, Richard Flavell suggested that this is due to the absence of an 
unknown L-selectin ligand on oligodendrocytes. In fact, lymphocytes were demonstrated 
to bind to the CNS white matter in vitro in a Stamper-Woodruff assay (Huang et al., 
1991; Huang et al., 1994). Thus, the binding of L-selectin to its ligand in the CNS can be 
responsible for the homing of activated lymphocytes to CNS and for the development of 
inflammation.  
In this thesis, in contrast, it is shown that the absence of L-selectin is not affecting the 
priming and the expansion of inflammatory cells in vivo. SJL/L-selectin-deficient mice 
are able to develop EAE following active immunization with the antigen proteolipid 
protein. These results confirm that, even in the absence of L-selectin, naïve T cells can 
enter the lymph nodes and can be activated in response to the PLP antigen, before they 
migrate across the BBB and induce inflammation in the CNS. Furthermore, CD45 
positive inflammatory cells were detected not only in the perivascular spaces, but are also 
detected in the CNS parenchyma, and no difference between SJL/L-selectin-deficient 
mice and SJL wild type littermates is seen. In the present study it is also shown that in 
vitro activated CD4 positive encephalitogenic T cells can induce EAE in recipient mice. 
Despite the results obtained by the group of Richard Flavell, the adoptive transfer of in 
vitro activated established PLP-specific T cell blasts, which originated from SJL wild 
type T cell line, induce the development of tEAE in SJL/L-selectin-deficient mice. In 
addition, it is also shown that in vitro activated primary T cell blasts generated from 
SJL/L-selectin-deficient mice are able to induce the development of tEAE in syngeneic 
recipients.  
The contradictory results are due to the different characteristics of SJL and C57Bl/6 
mice. In fact, it is known that SJL mice develop a relapsing-remitting EAE, which is 
characterized by development of the disease followed by a remission of the disease and 
the disease is accompanied by edema formation. C57Bl/6 mice, instead, develop a 
chronic disease and the CNS is demyelinised. Besides, the group of Richard Flavell used 
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mice which were transgenic for the myelin basic protein T cell receptor (MBP-TCR). 
Because of the constitutive expression of the T cell receptor specific for MBP on the 
lymphocyte surface, the MBP-TCR transgenic mice are known to develop severe disease 
shortly after immunization with MBP peptide (Lafaille et al., 1994). In this study, 
instead, mice were only deficient for L-selectin expression on lymphocytes. 
To conclude, the differences detected in this thesis compared to the data obtained by the 
group of Richard Flavell suggest that the role of L-selectin in the pathogenesis of EAE 
and in the recruitment of inflammatory cells across the BBB needs to be further 
investigated. In fact, from the study with C57Bl/6-CD62L-deficient mice it was 
concluded that the expression of L-selectin on effector cells is important for the 
demyelination of the CNS in EAE. From the study performed with SJL/L-selectin-
deficient mice, instead, it is possible to conclude that L-selectin is not required for the 
immunopathogenesis of EAE and for the recruitment of inflammatory cells across the 
BBB. In addition, a lot of discrepancies were also detected in the studies performed by 
blocking L-selectin with monoclonal antibodies (Archelos et al., 1998; Brocke et al., 
1999) compared to the investigations made using L-selectin-deficient mice. It was 
suggested the existence that in the absence of L-selectin, lymphocytes are primed in the 
spleen. Priming and activation of naïve lymphocytes in the spleen could explain why 
SJL/L-selectin-deficient mice developed EAE. Furthermore, it still has to be further  
investigated whether oligodendrocytes present a novel L-selectin ligand on their surface. 
The existence of this ligand was shown in vitro on frozen sections of EAE affected mice 
(Huang et al., 1991), but at present the ligand was not yet characterized. 
Hence, it is shown that the molecules and the mechanisms involved in the migration of 
encephalitogenic T cells across the BBB into the CNS are far to be completely 
understood. This means that the field is open for further investigations. 
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A. SUMMARY 
 
The role of adhesion molecules in the recruitment of inflammatory cells across the blood-
brain barrier (BBB) and in the pathogenesis of experimental autoimmune 
encephalomyelitis (EAE), the animal model for multiple sclerosis (MS), was already 
demonstrated. The role of L-selectin in the immunopathogenesis of EAE is still not 
clarified. In fact, previous investigations were not conclusive. To address whether L-
selectin, the homing receptor for lymphocytes to peripheral lymph nodes (PLN), is 
involved in the development of EAE, SJL/L-selectin-deficient mice were generated. 
After the characterization of SJL/L-selectin-deficient mice, which were generated 
backcrossing L-selectin-deficient mice into the EAE susceptible SJL mouse strain, EAE 
was induced by active immunization (aEAE) with proteolipid protein (PLP) in complete 
Freund’s adjuvant (CFA). The disease symptoms in SJL/L-selectin-deficient mice and in 
SJL wild type mice were indistinguishable, and in the CNS of EAE affected mice 
massive CD45 positive cell infiltrates were detected. EAE was also induced by adoptive 
transfer (tEAE) of encephalitogenic T cell blasts in SJL/L-selectin-deficient and SJL wild 
type mice. By transfer of SJL wild type PLP-specific T cell blasts in both mouse strains 
EAE symptoms were detected. It was not possible to generate stable SJL/L-selectin-
deficient PLP-specific T cell lines, thus by transfer of primary SJL/L-selectin-deficient 
and SJL wild type T cells in syngeneic recipients tEAE was induced. Primary PLP-
specific SJL/L-selectin-deficient and SJL wild type T cells induced disease in both 
mouse groups, and in the perivascular spaces and in the parenchyma CD45 positive cell 
infiltrates were detected. The migration efficiency of primary PLP-specific SJL wild type 
and SJL/L-selectin-deficient T cells across an endothelium was evaluated in vitro by 
Trans-Endothelial Migration (TEM) assay. SJL/L-selectin-deficient primary PLP-
specific T cells migrated across the endothelium and their migration in the presence of 
anti ICAM-1 antibodies, compared to the isotype control, was reduced. Taken together, it 
is possible to conclude that L-selectin is not involved in lymphocyte recruitment across 
the BBB during EAE, but still further investigations are required. In fact, the 
development of EAE in SJL/L-selectin-deficient mice suggests that lymphocytes can be 
primed in other organs than PLN, such as in spleen, and suggests the existence of L-
selectin ligands in the CNS, which are not yet identified. 
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